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with ‘hay fever’), house dust mite, ani-
mal dander (e.g. dog and cat), insects 
(cockroaches) and moulds – are causal 
factors, although these may differ by 
country and region.5  Atopy describes 
the familial syndrome of asthma and 
hay fever. the atopic state can be rec-
ognized by elevated serum ige levels, 
and a positive skin test which detect 
ige directed against allergens.6
furthermore the term asthma con-
trol is used in this thesis. Asthma con-
trol is not an unambiguous concept 
and the definition used in this thesis is 
likely to change in the future. asthma 
control is linked to asthma severity7 
and although related, asthma control 
and asthma severity are not the same. 
asthma severity describes the underly-
ing disease in the absence of therapy, 
whereas asthma control describes 
the clinical status of disease during 
intervention.8  this means that poor 
asthma control can be present with 
mild severity of the disease, but on the 
other hand, severe asthma can be well 
controlled.  
Risk factors for asthma
patients typically contact their gp 
for a variety of reasons: symptoms, 
abnormal findings, need for health 
information, etcetera. the patient’s 
presentation can point to a specific 
disease, but often there are different 
interpretations possible. in order to 
identify patients that are in need of 
further evaluation or treatment for a 
specific disease, general practitioners 
(gps) make use of the presence of risk 
factors9. this approach is also appli-
cable for patients with asthma. when 
a patient with asthma symptoms de-
cides to consult the gp, in most cases 
there has been quite a period of vari-
ous, intermittent complaints. these 
respiratory symptoms (cough, sputum, 
wheeze and shortness of breath) are 
not specific to asthma and are there-
fore also presented to gps by patients 
with other health problems. therefore, 
in order for a gp to diagnose asthma, 
respiratory symptoms should be as-
sessed in the light of the presence of 
possible risk factors for asthma 9. 
asthma has significant genetic and 
environmental components, but the 
exact pathogenesis is currently not 
clear and conclusive risk factors for 
asthma have yet to be identified. Sev-
eral factors like airway hyperrespon-
siveness (ahr)10-12, atopy and allergic 
rhinitis are associated with asthma. 
however, it is not clear whether these 
factors are present in asthma patients 
preceding the actual development of 
the disease, and thus can be marked as 
risk factors; if they are conditions that 
are consistent with (a very mild state 
of) asthma which may develop in clini-
cally manifest asthma; or if they are 
coincidental conditions.
allergic rhinitis (ar) is known to be 
related with asthma. Cross-sectional 
studies have shown that ar and asthma 
frequently coexist. up to 80% of all 
asthma patients have concomitant ar 
and over 20% of ar patients also have 
a diagnosis of asthma.13;14 results from 
a growing number of studies suggest 
that ar and allergic asthma are mani-
festations of the same disease entity: 
‘one airway, one disease’. 15;16 Still, not 
all patients with ar eventually pres-
ent asthma and not all patients with 
asthma have ar. although a prospec-
tive relationship is suspected, very few 
longitudinal studies have been con-
ducted that confirm this wide spread 
concept.17-20 
ahr is a characteristic feature of 
asthma in which the airways over-re-
spond to various stimuli that are harm-
less to non-asthmatic persons 4. this 
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InTRoduCTIon
in this thesis several studies on pos-sible risk factors for asthma and in-
dicators of poor asthma control are 
described. the general objectives are 
to contribute to timely diagnosis of 
asthma and to search for an practical 
way to detect patients with poorly 
controlled asthma in general practices. 
i will first discuss the background of 
this thesis and some important con-
cepts and general principles that were 
used, before addressing the research 
questions and clarifying the research 
methods used. 
BACkGRound
asthma is a chronic, inflammatory, 
pulmonary disease with a significant 
impact on patients, their families, and 
society. its prevalence has increased 
over the last few decades 1;2 (figure 
1). this makes it a major public health 
problem and explains why  any reduc-
tion of the impact of asthma will have a 
major effect on public health. 
asthma is a very frequent chronic 
disease in childhood, however, new 
onset of asthma is also common in 
adolescence and early adult life, lead-
ing to the need for studies in this age 
group. asthma is mostly diagnosed 
and treated in general practice and, as 
the symptoms are of a variable charac-
ter, the diagnosis of asthma may pose a 
challenge for gps. 
ConCepTs used  
In ThIs ThesIs:
in this thesis, the following concepts 
are used: Risk, the probability that a 
health problem will occur, e.g., the 
probability that an individual will be-
come ill (in this thesis: asthma)3. Risk 
factor, an item of personal behaviour 
or lifestyle, exposure, or an individual 
characteristic which may be inherited 
and which is known to be associated 
with ill health or considered important 
in prevention of health problems. it 
does not necessarily imply a cause and 
effect relationship.3  Airway hyper-
responsiveness (AHR), also known as 
bronchial hyperresponsiveness (Bhr) 
is a characteristic feature of asthma 
with exaggerated airway narrowing 
in response to various stimuli that are 
harmless to non-asthmatic persons. 
ahr can be assessed in several ways, 
e.g. with a histamine provocation test.4 
Allergic rhinitis (AR): is defined by the 
presence of sneezing, nasal discharge, 
postnasal drip, itchy nose and bilat-
eral nasal obstruction. allergic triggers 
– most commonly pollen (associated 
Introduction
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toms and consequently requires a 
long-term commitment of the patient 
and the gp. periodic checkups to assess 
whether treatment has been effective 
and whether the patient is compliant 
towards the initiated treatment are 
very important. unfortunately, despite 
the availability of appropriate manage-
ment for asthma, poorly controlled 
asthma is still reported in a substantial 
number of patients 34;35. among other 
factors, patients’ poor compliance, 
knowledge of asthma medication, and 
poor adherence towards regular con-
trol visits may explain this suboptimal 
control.36;37 there are also indications 
that patients and physicians overesti-
mate the level of asthma control.34;35 
this underlines the need for a tool that 
can measure asthma control in order 
to identify those asthma patients that 
are in need of medical attention. Bron-
chial inflammation can be an objective 
marker for poor asthma control and 
can be assessed by induced sputum 
eosinophilia38, nitric oxide (no) mea-
surement or airway hyperresponsive-
ness.39 however, the requirement of 
laboratory facilities, their time-con-
suming nature, and patient-unfriend-
liness severely hamper their routine 
use in primary care. as an increase of 
asthma symptoms has been shown to 
reflect loss of asthma control,40;41 this 
makes measurement of changes in 
asthma symptoms an attractive alter-
native. 
ReseARCh 
QuesTIons
as mentioned earlier, in this thesis 
studies on possible risk factors for 
asthma and indicators of poor asthma 
control are described. the following 
research questions are addressed:
1. what is the natural history of respi-
ratory symptoms and asthma/ahr in a 
primary care population? (Chapter 2)
2. is asymptomatic ahr in adoles-
cence a risk factor for asthma in adult-
hood? (Chapter 3)
3. is a physician diagnosis of allergic 
rhinitis a risk factor for the develop-
ment of physician diagnosed asthma? 
(Chapter 4)
4. Can the asthma Control Question-
naire (aCQ) be used to differentiate be-
tween patients with good and poorly 
controlled asthma? (Chapter 5)
5. Can a postal mailing of the aCQ 
be used to detect the asthma patients 
with suboptimal symptom control in 
general practice? (Chapter 6)
in order to outline where the differ-
ent studies of this thesis are situated in 
the continuum between undiagnosed 
disease and diagnosed and treated 
asthma, figure 2 reflects a simplified 
version of a common pathway of a pa-
tient with diagnosed asthma.
Chapters 2-4 used data from the 
nijmegen ‘Continuous morbidity reg-
istration’  (Cmr)42-46. the Cmr is a 
general practice research network and 
provides a database in which the gp 
diagnoses (morbidity) for each patient 
and for each episode of outpatient 
care are coded and recorded. in 1989 
a cohort of adolescents was invited 
for a baseline assessment of their re-
spiratory health status. the patients 
were born between 1967-1979 and 
registered with one of the four Cmr airway narrowing leads to variable air-
flow limitation and intermittent symp-
toms like wheezing, breathlessness, 
chest tightness and coughing. ahr can 
be assessed in several ways, e.g. with 
a histamine provocation test. ahr is 
closely related with asthma21, but there 
is no complete overlap between ahr 
and asthma.22;23. epidemiologic studies 
have reported that 7-16% of subjects 
with ahr have so called asymptom-
atic ahr, i.e. ahr without concurrent 
respiratory symptoms nor a medical 
history with asthma.22;24-26 it has been 
suggested that asymptomatic ahr is 
a precursor of asthma and therefore 
associated with a higher risk for devel-
opment of asthma. But contradicting 
study results have been presented27-
31, which warrants further research to 
study this presumed relationship. 
Asthma control
once asthma is diagnosed, again 
the course of the disease can differ 
between patients. therefore, it is vi-
tal that gps (and other healthcare 
professionals) know at which point to 
intervene, and at which point not to 
intervene.
although there is no cure for asthma, 
appropriate management will often 
result in achieving better control. ac-
cording to global asthma management 
guidelines (global initiative for asthma 
(gina) guidelines),32 asthma control 
is exhibited by the following: a mini-
mum of chronic symptoms -including 
nocturnal symptoms-, no exacerba-
tions, minimal need for as-required 
β2-agonists, and no limitations to daily 
activities and a normal lung function 
(measured by peak expiratory flow 
(pef), or forced expiratory volume in 
one second, fev1). the gina guidelines 
specify these goals for the long-term 
management of asthma and these 
treatment objectives are also pursued 
in primary care guidelines such as the 
dutch College of general practitio-
ners’ guideline for asthma in adults. 
33 treatment of asthma consists of 
both non-pharmacological treatment, 
such as advise on lifestyle and aller-
gen avoidance, as well as treatment 
with medication. the treatment is to 
a large extent directed at the preven-
tion of recurrence of signs and symp-
Figure 1. Prevalence of asthma in CMR 2-6
Figure 2
Figuur 2, hoofdstuk 1 (zelfde als in hoofdstuk 8)
Figure 2.
Undiagnosed 
asthma
Asthma 
diagnosis
Diagnosed and treated* asthma
*Consists of initiation of asthma treatment and maintenance therapy with concurrent 
control visits
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practices. they underwent lung func-
tion testing, including spirometry and 
a histamine provocation test47-50, com-
pleted a respiratory symptom ques-
tionnaire, and had their allergy status 
assessed by phadiatop testing. 51 in 
Chapter 2 the Cmr-recorded respira-
tory tract morbidity of this cohort was 
followed up until 2000 when the cohort 
was aged 21-33 years. in Chapter 3 the 
respiratory health status of the cohort 
was reassessed in 2003 when the co-
hort was aged 23-36 to assess the pre-
dictive value of asymptomatic ahr and 
the presence of allergy in adolescence 
for asthma in young adulthood. 
the study described in Chapter 4 did 
not make use of the cohort described 
in Chapters 1 and 2 but used the Cmr 
population as a whole and assessed 
whether allergic rhinitis was a risk fac-
tor for the development of asthma.  
Chapter 5 and 6 were based on a 
multi-centre, observational, cross-sec-
tional study. nine general practices in 
the nijmegen and amsterdam areas 
participated in this study.
Chapter 5 explored whether valid 
differentiation is possible between 
asthma patients with controlled and 
uncontrolled asthma symptoms, on 
the basis of a short symptom question-
naire: the asthma Control Question-
naire (aCQ). 
 an instrument that can differentiate 
between well-controlled asthma and 
poorly controlled asthma can only con-
tribute to better care when it is able 
to reach potentially poorly controlled 
asthma patients. as not all asthma pa-
tients consult their general practice on 
a regular basis, other means need to be 
used to reach them. 
Chapter 6 investigated whether a 
postal mailing of the aCQ can be used 
to detect the asthma patients with (po-
tential) suboptimal symptom control in 
general practice. 
Chapter 7 is a response to a paper 
published by other investigators which 
provided a general practice view to the 
opinion that asthma control is only an 
important variable in clinical studies.
Chapter 8 contains a discussion of 
the main conclusions and recommen-
dations of this thesis and puts them in 
perspective.
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ABSTRACT
BACKGROUND We examined the natural history of asthma in a primary care 
cohort of patients 10 years after the cohort was stratifi ed for asthma risk by 
responses to a questionnaire and bronchial hyperresponsiveness (BHR) testing.
METHODS Children and young adults who were born between 1967 and 1979 
within 1 of 4 affi liated family practices of the Nijmegen Department of Family 
Medicine, the Netherlands, were asked to participate in an asthma study in 1989. 
Of 926 patients available, 581 (63%) agreed to participate. Their family physi-
cians’ diagnoses of upper and lower respiratory tract disease and asthma were 
prospectively collected during the next 10 years and were analyzed.
RESULTS BHR or the presence of asthma symptoms at screening did not result 
in a signifi cantly disproportionate number of physician visits during the next 10 
years for 4 or more upper or lower respiratory tract infections when compared 
with patients who did not have these fi ndings at the beginning of the study. The 
presence of asthma symptoms correlated with an increased risk of an asthma 
diagnosis or allergic rhinitis in the group of patients who did not have asthma 
diagnosed at start of the study. One half of the known asthmatic patients at the 
onset of the study (21 of 44) had no further visits to their physicians for treatment 
of asthma during the next 10 years.
CONCLUSIONS In primary care, BHR testing has limited value in predicting subse-
quent respiratory tract disease for patients who have asthma diagnosed by a physi-
cian. The use of symptom questionnaires can be of clinical use in predicting asthma. 
Ann Fam Med 2004;2:110-115. DOI: 10.1370/afm.40.
INTRODUCTION
The current view of asthma is that of a chronic disease with periodic clinical exacerbations,1 a considerable change from our previous view of asthma as primarily episodic in nature. The highly variable nature 
of the clinical course of asthma makes it diffi cult for physicians and patients 
to know at any given time how much treatment is necessary and for how 
long. Asthma is, in essence, still quite different from other chronic diseases, 
such as hypertension or hyperlipidemia, the natural histories of which we 
now know quite well. The only information about the natural history of 
asthma is based on relatively few cohort studies.2,3 Information about the 
natural history of asthma in primary care populations remains a missing link 
between our biological knowledge of the disease and our clinical manage-
ment of it. Insight into the natural history is complicated by the level of 
undiagnosed asthma.4-6 Underdiagnosis of asthma is as much a problem for 
asthma research as it is for practitioners. Although much has been attributed 
to physicians’ problems in interpretation of clinical information, there are 
growing indications that patients’ reluctance to complain of symptoms or to 
adhere to follow-up visits also contribute to underdiagnosis.6
Longitudinal outcome studies of primary care patients with asthma 
should help us create this linkage and understand the developmental 
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epidemiology of asthma. Such studies require reason-
able asthma defi nitions, stable primary care popula-
tions observed for prolonged periods, and—given 
the frequency of undiagnosed asthma—a population 
perspective. Most clinical studies of asthma have used 
a combination of bronchial hyperresponsiveness (BHR) 
testing and responses to respiratory questionnaires to 
assist with an asthma diagnosis. Use of these diagnos-
tic tools is consistent with recommendations from the 
American Thoracic Society,7 World Health Organiza-
tion, and National Heart, Lung and Blood Institute.8
Others have used physician diagnosis as the standard. 
Long-term follow-up remains a problem, partly because 
diagnosed asthma frequently disappears later on. 
Whether asthma disappears as a consequence of the 
natural history of asthma, adherence by the patient to 
treatment, or another phenomenon is not well known.
To improve our knowledge of the natural history of 
asthma, we observed a primary care cohort of children 
and adolescents that had been screened 10 years earlier 
for respiratory tract signs and symptoms by Kolnaar et 
al.9,10 The objective of the current study was to clarify 
the natural history of respiratory tract complaints and 
asthma in primary care.
METHODS
In 1989, a cohort of children and young adults from 
4 affi liated family practices in the Netherlands was 
identifi ed for an asthma study based on date of birth.9,10
Given the structure of the Dutch health care system, 
this cohort refl ects the characteristics of the popula-
tion.11 The study of Kolnaar et al9,10 assessed the rela-
tion of early childhood respiratory tract morbidity and 
asthma in adolescence. For that reason, the study was 
confi ned to the 926 patients drawn from all the chil-
dren born in Continuous Morbidity Registration prac-
tices (addressed below) between 
1967 and 1979, and who were 
still registered with the practices 
in 1989. The study cohort did 
not differ from the original birth 
cohort in terms of respiratory 
tract morbidity, but patients were 
more often of lower social class.9
From this group, 581 agreed to 
participate, and 551 (60%) were 
able to complete the testing and 
questionnaire satisfactorily for 
interpretation. Again, there were 
no essential differences between 
participants and nonparticipants 
with regard to respiratory tract 
morbidity. All participants were 
screened for asthma by a symptom questionnaire and 
BHR testing.4,9,10 The respiratory symptom questions 
used in this study are displayed in Table 1. This ques-
tionnaire was based on the children’s version of the 
respiratory symptom surveys of the British Medical 
Research Council and American Thoracic Society.12
Patients were considered symptomatic if they answered 
”yes” to the questions 1, 3, 4, or 5 (Table 1).
Histamine challenge testing was assessed by the 
concise version of the European Respiratory Society 
standardized testing procedure.13 If the provocative con-
centration of histamine causing a 20% decline in forced 
expiratory volume (FEV1) was ≤8.0 mg/mL (PC20), the 
study participants were considered to have a positive 
BHR test. Details of this study have been previously 
described.10 At the conclusion of this 1989–1990 study, 
all participants and their families were informed of their 
results, and those with symptoms or evidence of BHR 
were advised to visit their family physician. 
No relation could be found between early child-
hood respiratory tract morbidity (mainly infections) 
and asthma, respiratory symptoms, or BHR testing 
results in 1989.9 There was a substantial undiagnosed 
frequency of asthma (10%),4 however, and we were 
intrigued by the high frequency of BHR (39%) in oth-
erwise healthy adolescents without symptoms.10
Since 1967, 4 family practices associated with the 
University of Nijmegen in the southeast of The Neth-
erlands have been continuously collecting outpatient 
morbidity data from all the patients they serve, a pro-
cess now called the Nijmegen academic family practice 
research network Continuous Morbidity Registration 
(CMR).11,14 The CMR was the source of the population 
and morbidity data for this study. The CMR provides 
a database in which the physician diagnoses (morbid-
ity) for each episode of outpatient care are coded and 
recorded. Each patient has a unique identifi er number 
Table 1. Respiratory Questionnaire Items
Symptom Questions
Chronic cough 1.  Did you usually, at least 5 days per week, cough (when getting up or dur-
ing the day or night) during a period of at least 3 consecutive months?
Chronic phlegm 2.  Did you usually, at least 5 days a week, bring up phlegm (when getting up, 
or during the day, or at night) for at least 3 consecutive months?
Chronic cough 
with phlegm
3. Have you coughed up phlegm, more than usually, for at least 3 consecu-
tive weeks in the last 12 months?
Wheezing 4.  Have you had wheezing in your chest in the last 12 months?
Tightness with 
wheezing
5. Have you had attacks of tightness with wheezing in your chest (attacks of 
asthma) in the last 12 months?
Breathless, age 6.  Do you think that you get breathless more quickly than friends of your 
own age?
Breathless, upstairs 7.  Have you been breathless going upstairs or riding a bike at a normal pace 
at least once in the last 12 months?
Breathless, fl at 8.  If yes, have you been breathless when you walked on the fl at at a normal 
pace at least once in the last 12 months?
Smoking behavior 9. Do you smoke? Have you ever smoked, and did you stop smoking?
2 Chapter 2  natural history
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assigned at the point of care to which the coded mor-
bidity is assigned, and this information is attached to 
other demographic data available for the patient. The 
physicians within the 4 practices meet regularly to dis-
cuss classifi cation and coding issues to assure accuracy. 
Confi dentiality is assured by having the identifi er codes 
available only at the physician offi ces. 
The Dutch health care system is ideally suited for this 
type of morbidity study because all patients are registered 
with a family physician, and all access to care must come 
through this physician. Family physicians’ records include 
information of diagnosis and treatment by any other 
physician to whom the patient may have been referred. 
The CMR database includes, therefore, all diagnoses 
made through specialist care; for this study, respiratory 
tract diagnoses were made by chest physicians, internists, 
and pediatricians in addition to family physicians. Nearly 
everyone is insured by a single payer source, and the 
population is relatively stable. These factors allow excel-
lent patient tracking and outstanding opportunities for 
studying disease longitudinally.
For this study, patient records were reviewed up to 
2000. All but 7 patients could be found for follow-up, 
and data were available for 323 (59%) patients for the 
full 10-year period.
At the end of the 10 years of follow-up care, we 
reviewed the records of cohort patient visits to their 
family physicians, looking for respira-
tory tract problems diagnosed by the 
physicians. The outcomes of the 1989-
1990 screening period (symptomatic 
vs asymptomatic, BHR positive vs 
BHR negative, and the combination 
of symptomatic and BHR positive vs 
asymptomatic and/or BHR negative) 
were related to CMR-recorded respi-
ratory tract morbidity from 1990 to 
2000. Patients who had asthma diag-
nosed by their family physician before the 1989–1990 
screening period were dealt with separately in the analy-
sis. The analysis used the 1989 respiratory tract status 
of the patients (respiratory symptoms and BHR) as the 
independent variables, and the 1990–2000 respiratory 
tract morbidity diagnosed by their family physicians as 
the dependent variable. We used the Cox proportional 
hazard analysis to calculate the hazard ratio for getting 
an asthma diagnosis.
RESULTS
Almost all 544 participants had at least 1 physician visit 
during the 10 years of the study. Fifty percent (272) of 
the population were women. The average age of the 
cohort at follow-up was 25 years for women and 24 
years for men. Asthma was diagnosed at one time or 
another in 63 of the 544 patients (11.6%), of which 44 
had asthma diagnosed at the onset of the study and 19 
had asthma diagnosed after 1989.
From Table 2 it is apparent that the chance of having 
asthma diagnosed is signifi cantly increased if patients 
are symptomatic or are of younger age. Remarkably, 
the chance is not signifi cantly increased if patients have 
BHR, and there is no difference by patient sex.
Table 3 relates the baseline symptoms and BHR 
fi ndings to subsequent upper and lower respiratory 
Table 2. Hazard Ratio for Getting an Asthma Diagnosis (N = 500)
Variable Hazard Ratio
95% Hazard Ratio 
Confi dence Limits P Value
Symptomatic* 3.414 1.386, 8.410    .008
Bronchial 
hyperresponsiveness
1.278 0.519, 3.148    .59 
Age 0.816 0.687, 0.969    .02
Male 1.230 0.499, 3.031    .65
* Symptomatic means ≥1 positive answer to the respiratory tract symptom questionnaire in 1989.
Table 3. Respiratory Tract Symptoms of 298 Active Patients Still in Practice Without an Asthma 
Diagnosis at Start of Study
Symptoms
BHR
No. (%)
Non-BHR
No. (%)
RR
(95% CI)
P
Value
Symptomatic*
No. (%)
Asymptomatic
No. (%)
RR
(95% CI)
P
Value
>4 upper respiratory 
tract infections†
16 (13)      21 (12) 1.1 (0.6–2.3)       .70       10 (16) 27 (11)  1.5 (0.7–3.2)    .34
Lower respriatory 
tract infections‡
18 (15)      16 (9) 1.8 (0.9–3.6)       .10         6 (10) 28 (12)  0.8 (0.3–2.0)    .46
Allergic rhinitis 18 (15)      21 (12) 1.3 (0.7–2.6)       .45       16 (25) 23 (10)  3.1 (1.5–6.4)    .001
Asthma 8 (7)       8 (5) 1.5 (0.5–4.1)       .40         8 (13) 8 (3)  4.1 (1.5–11.5)    .01
Total 121 (100)    177 (100)       63 (100) 235 (100)
BHR = bronchial hyperresponsiveness; RR = relative risk; CI = confi dence interval. 
* ≥1 positive answer to the respiratory tract symptom questionnaire in 1989.
† Includes otitis media, infl uenza, acute sinusitis, and laryngitis diagnoses.
‡ Includes pneumonia and acute bronchitis.
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tract infections, allergic rhinitis, and asthma for the 
298 patients who were still active in the practices and 
did not have a diagnosis of asthma at the start of the 
study. It is apparent that those patients with BHR dif-
fered little from those with no BHR in the likelihood of 
having their physician diagnose upper or lower respira-
tory tract infections, allergic rhinitis, or asthma. Those 
who answered affi rmatively to 1 or more of the asthma 
questions in 1989 also did not differ greatly in their 
likelihood of subsequently visiting their physicians with 
respiratory tract infections. They did, however, have a 
signifi cantly higher chance of having asthma diagnosed 
(P = .01, relative risk [RR] = 4.1, 95% confi dence inter-
val [CI], 1.5–11.5) or an allergic rhinitis diagnosis (P = 
.001, RR = 3.1, 95% CI, 1.5–6.4). 
We compared the outcomes of those members of 
the cohort thought to be most at risk for respiratory 
tract problems, ie, those who had a positive BHR test 
and were symptomatic, with those who had a nega-
tive BHR test and were asymptomatic. The 2 groups 
did not appear to differ in the diagnoses of upper and 
lower respiratory tract infections. The absolute risk of 
an asthma diagnosis in this subgroup of symptomatic 
hyperresponders (n = 50), however, was 10% compared 
with 2.6% for those who did not have these character-
istics (P = .04).
DISCUSSION
This study shows that in this cohort of children and 
young adults, a single positive test for BHR has limited 
prognostic importance for subsequent respiratory tract 
illness, including asthma. Because this cohort contains 
a specifi c age-group, these results are not generalizable 
to a different age-group. Nevertheless, the prevalence 
of asthma of 20 in 1,000 in the study population is in 
the high-normal range of the Dutch adolescent primary 
care population,15,16 so the a priori likelihood of asthma 
is representative of the family practice setting. More 
than 50% of patients with asthma did not have asthma 
diagnosed by their family physician,4 which highlights 
the relevance of case fi nding.
The results of this study may mean that BHR test-
ing has limited ability to capture the disease accurately. 
We showed, however, that more than 1 positive answer 
to questions 1, 3, 4, or 5 on the respiratory symptom 
questionnaire does correlate with an increased diagno-
sis of asthma in the future.
This study was aimed at all children and adolescents 
in the (practice) population and consequently included 
those with mild and moderate respiratory symptoms. It 
therefore describes the natural history of asthma as an 
episodic disease for which most patients will have no 
major diffi culties into adulthood.
Despite the relatively nonspecifi c symptoms that 
characterize asthma, various asthma symptom question-
naires have been developed with validation studies to 
support their use.17-19 These studies found that ques-
tionnaires were better than BHR testing as screening 
tools for asthma. This study confi rmed these outcomes. 
The studies also found that the positive predictive 
value of symptoms for an asthma diagnosis or for sub-
sequent problems was limited. On the basis of our fi nd-
ings, we calculated a predictive value of 13%, which is 
in line with the low prognostic value reported by oth-
ers. We also found that those who had no symptoms 
gained little prognostic information from BHR testing. 
It appears that in the epidemiologic study of respiratory 
tract disease, BHR testing is most useful after respira-
tory symptoms have been assessed.
Respiratory tract infections, in particular viral infec-
tions, increase airway infl ammation and thus may pro-
voke or increase symptoms in patients with asthma.20,21
For that reason, it might be expected that patients with 
asthma would visit their physician more often than 
nonasthmatic patients for respiratory tract infections. 
Our data, however, did not confi rm this expectation. 
BHR is a marker of airway infl ammation; for that rea-
son, we were particularly interested in the patients who 
were asymptomatic in 1989 for BHR. The lack of respi-
ratory tract episodes in the 10 years of follow-up make 
it improbable that in our cohort BHR heralded an early 
state of airway infl ammation, which might be an impor-
tant difference from the other studies.
In 1962, BHR was included in the already estab-
lished defi nition of asthma as a disease characterized 
by reversible airfl ow obstruction.22 A single BHR read-
ing seems insuffi cient, however, to yield much useful 
information. When we applied more stringent criteria 
to the defi nition of BHR by reducing the PC20 cutoffs 
for FEV1 to ≤4 mg/mL, ≤2 mg/mL, and ≤1 mg/mL, 
we obtained fewer hyperresponsive patients, but a 
larger percentage of those had physician-diagnosed 
asthma. Because severity of BHR appears to correlate 
with asthma and a poorer outcome,23 this fi nding is 
not surprising. In changing the diagnostic criteria, we 
improved the specifi city of these tests for an asthma 
diagnosis, but in exchange, we diminished the sensitiv-
ity of the test to detect asthma. Josephs et al24 found 
that PC20 measurements did not consistently correlate 
with exacerbations of asthma. Pattemore et al25
believed that BHR testing could “not reliably or pre-
cisely separate asthmatics from nonasthmatics in the 
general community.” Salome et al26 studied BHR, respi-
ratory tract symptoms, and asthma in 2,363 Australian 
children and noted that the association between these 
parameters and asthma is signifi cant but incomplete. 
Britton and Tattersfi eld27 suggested that the validity of a 
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positive BHR test in the clinical diagnosis of asthma is 
limited. Rasmussen et al28 in their Odense Schoolchild 
Study showed that in 10 years of follow-up, those with 
asymptomatic BHR on exercise testing had a weakly 
associated increase in coughing and wheezing. Many 
other community studies have confi rmed the weak 
association between asymptomatic BHR and the subse-
quent development of asthma.29,30 Laprise and Boulet,31
however, showed that patients with asymptomatic 
airway hyperresponsiveness had a greater increase in 
airway responsiveness and frequency of development of 
asthma symptoms than did normoresponsive patients. 
Zhong et al32 reported that 45% of asymptomatic stu-
dents with positive BHR tests developed asthma in the 
following 2 years. 
The strength of the CMR database is its complete-
ness and the reliability of its recorded morbidity data.33
This study does not elucidate the qualitative experi-
ences of the cohort in regard to respiratory disease 
and has selected only to look at the morbidity of this 
group recorded by their physicians in the 10 years 
after testing. The number of cases of asthma in the 
community, however, is not well known to the family 
physician.4 Van den Boom et al34 showed in his primary 
care DIMCA study that a great many adults have con-
siderable respiratory tract diffi culties that they have not 
made known to their physician. This fi nding remains 
fascinating, because effective treatment of asthma is 
possible and from a physicians’ perspective desirable. 
By not telling physicians about their symptoms of 
asthma, patients hamper the implementation of such 
treatment. A qualitative study to explore the patient’s 
perspective is planned in a later phase of this study. 
We have found BHR testing does not help us a 
great deal with determining who will have problems 
and who will require an intervention. We did fi nd, 
however, that a positive answer to the asthma symptom 
questionnaire was associated with an increased risk of 
an asthma diagnosis in the future, which suggests that 
the use of an asthma symptom questionnaire does have 
clinical signifi cance. Until we better understand the 
natural history of asthma in primary care and fi nd bet-
ter ways of looking for and treating patients at most 
risk, we will need to continue to be cautious about its 
diagnosis and management.
CONCLUSIONS
The majority of those with diagnosed asthma or asth-
ma symptoms in primary care do not have continuous 
problems with the disease.
A single test for BHR has a relatively low predictive 
value for adverse respiratory tract outcome.
More than 1 positive answer to an asthma symptom 
questionnaire increases the chance for patients having 
asthma diagnosed in the future.
To read commentaries or to post a response to this article, see it 
online at http://www.annfammed.org/cgi/content/full/2/2/110.
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Chapter 2  natural history
Are asymptomatic airway
hyperresponsiveness and allergy risk
factors for asthma? A longitudinal study
L. van den Nieuwenhof*, T. Schermer*, Y. Heijdra#, B. Bottema*, R. Akkermans*,
H. Folgering" and C. van Weel*
ABSTRACT: Airway hyperresponsiveness (AHR) is a characteristic feature of asthma, but it is
unclear whether asymptomatic AHR is associated with a higher risk of asthma. The present study
assessed whether there is an association between asymptomatic AHR in adolescence and asthma
in adulthood. The association between allergy and development of asthma was also investigated.
A follow-up study of a general population cohort of adolescents was performed 14 yrs after
baseline. Respiratory status was assessed at baseline in 1989 and at follow-up in 2003–2004 by a
respiratory symptoms questionnaire, spirometry and histamine challenge. Allergy status was also
assessed.
The respiratory status of 199 subjects was assessed twice. In total, 91 (46%) subjects had the
same AHR status in combination with respiratory symptoms at follow-up as at baseline. Adjusted
for age, sex, allergy, family history of asthma and smoking history, having asymptomatic AHR was
not significantly related to having asthma 14 yrs later (odds ratio (OR) 2.15, 95% confidence
interval (CI) 0.67–6.83). For subjects with allergy at baseline, the OR for developing asthma was
4.45 (95% CI 1.46–13.54).
Screening for asymptomatic airway hyperresponsiveness in adolescence does not identify
subjects at risk of developing asthma. Conversely, the presence of allergy in adolescence does
seem to be a risk factor for asthma development.
KEYWORDS: Adolescents, airway hyperresponsiveness, asthma, asymptomatic, general practice,
longitudinal
A
irway hyperresponsiveness (AHR) is a
characteristic feature of asthma in which
the airways over-respond to various
stimuli, resulting in airflow obstruction [1].
AHR can be measured by means of a bronchial
challenge test, usually with histamine, metha-
choline or adenosine 59-monophosphate [2].
Although AHR is associated with current asthma
[3], there is no complete overlap between AHR
and asthma [4, 5]. Epidemiological studies have
reported that 7–16% of subjects with AHR have
asymptomatic AHR, i.e. AHR without concurrent
respiratory symptoms or a medical history of
asthma [4, 6–8]. It has been suggested that
asymptomatic AHR is associated with a higher
risk of developing asthma [9–11], with the
occurrence of (irreversible) structural and func-
tional changes in the airways [12–14]. Some
studies have reported that 14–58% of subjects
with initially asymptomatic AHR developed
asthma in the years after this observation [9–11].
Therefore, asymptomatic AHR could be an early,
pre-clinical state in the pathological process of
developing asthma. BOULET [15] has suggested use
of asymptomatic AHR to identify patients with a
higher risk and initiate treatment to prevent the
development of asthma. However, other investi-
gators have found no evidence that asymptomatic
AHR precedes symptomatic asthma [16, 17]. It is
essential in this context to distinguish between de
novo development of asthma via a state of
asymptomatic AHR and diagnosing asthma that
is as yet unrecognised by the patient and the
physician, in which AHR is one of the findings
supporting the diagnosis. This distinction is
important for the improved understanding of the
natural history of asymptomatic AHR in the
general population [15]. Most studies that
reported AHR to be related to the development
of asthma were either based on selected popula-
tions that had been referred to specialist care, or on
populations consisting of small numbers with the
risk of selective inclusion [9–12]. This underlines
the need to study the natural history of AHR in the
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ABSTRACT: Airway hyperresponsiveness (AHR) is a characteristic feature of asthma, but it is
unclear whether asy ptomatic AHR is associated with a higher risk of asthma. The present study
assessed whet er there is an association between asy ptomatic AHR in adolescence and asthma
in adulthood. The association between allergy and development of asthma was also investigated.
A follow-up study of a general populati n cohort of adolescents was performed 14 yrs after
baseline. Respiratory status was assessed at baseline in 1989 and at follow-up in 2003–2004 by a
respiratory sy ptoms questionnaire, spirometry and histamine challenge. Allergy status was also
assessed.
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same AHR status in combi ation with respiratory sy ptoms at follow-up as at baseline. Adjusted
for age, sex, allergy, family history of asthma and smoking history, having asy ptomatic AHR was
not significantly related to having asthma 14 yrs later (odds ratio (OR) 2.15, 95% co fidence
interval (CI) 0.67–6.83). For subjects with allergy at baseline, the OR for developing asthma was
4.45 (95% CI 1.46–13.54).
Screening for asy ptomatic airway hyperresponsiveness in adolescence does not identify
subjects at risk of developing asthma. Conversely, the presence of allergy in adolescence does
seem to be a risk factor for asthma development.
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irway hyperresponsiveness (AHR) is a
characteristic feature of asthma in which
the airways over-respond to various
stimuli, resulting in airflow obstruction [1].
AHR can be measured by means of a bronchial
challenge test, usually with histamine, metha-
choline or adenosine 59-mono hosphate [2].
Although AHR is associated with current asthma
[3], there is no complete overlap between AHR
and asthma [4, 5]. Epidemiological studies have
reported that 7–16% of subjects with AHR have
asy ptomatic AHR, i.e. AHR without concurrent
respiratory sy ptoms or a medical history of
asthma [4, 6–8]. It has been suggested that
asy ptomatic AHR is associated with a higher
risk of developing asthma [9–11], with the
occurrence of (irreversible) structural and func-
tional changes in the airways [12–14]. Some
studies have reported that 14–58% of subjects
with initially asy ptomatic AHR developed
asthma in the years after this observation [9–11].
Therefore, asy ptomatic AHR could be an early,
pre-clinical state in the pathological process of
developing asthma. BOULET [15] has suggested use
of asy ptomatic AHR to identify patients with a
higher risk and initiate treatment to prevent the
development of asthma. However, other investi-
gators have found no evidence that asy ptomatic
AHR precedes sy ptomatic asthma [16, 17]. It is
essential in this context to distinguish between de
novo development of asthma via a state of
asy ptomatic AHR and diagnosing asthma that
is as yet unrecognised by the patient and the
physician, in which AHR is one of the findings
supporting the diagnosis. This distinction is
important for the improve understanding of the
natural history of asy ptomatic AHR in the
general population [15]. Most studies that
reported AHR to be related to the development
of asthma were either based on selected popula-
tions that had been referred to specialist care, or on
populations consisting of small numbers with the
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general population in initially asthma-free, truly asymptomatic
subjects.
The present study reports follow-up after 14 yrs of a cohort of
adolescents recruited from the general population, with a 24%
baseline prevalence of asymptomatic AHR [18–21]. The
primary aim was to assess prospectively whether there is an
association between asymptomatic AHR in adolescence and
the development of asthma in adulthood in this cohort. The
current authors also assessed whether or not the presence of
allergy is associated with an increased risk of developing
asthma.
METHODS
Study design and subjects
The present study was a follow-up of a cross-sectional cohort
study conducted in 1989 [19–22]. The initial study group was a
cohort of subjects born in 1967–1979 and registered with one of
the four general practices of the Nijmegen Continuous
Morbidity Registration (CMR), an academic general practice
network [23]. Given the structure of the Dutch healthcare
system, this cohort represents the characteristics of the Dutch
population [24]. In 1989, when the subjects were aged 10–
22 yrs (mean¡SD 15.9¡3.2 yrs), all subjects were invited for a
baseline assessment of their respiratory status using a
respiratory symptoms questionnaire, spirometry (including
reversibility testing with salbutamol), an allergy test and a
histamine challenge test.
For the current study, all subjects of the initial cohort were
eligible for a follow-up assessment in 2003–2004. Subjects were
invited via a letter from their general practitioner (GP). Subjects
who had moved since 1989 were traced through the general
practice to their last known address. A reminder letter was sent
8 weeks after the first invitation letter.
The study was approved by the Committee on Research
Involving Human Subjects of the Radboud University
Nijmegen Medical Centre (Nijmegen, the Netherlands), and
written informed consent was obtained from all participants.
Measurements and definitions
During the follow-up visit in 2003–2004, the respiratory status
was assessed again with the same respiratory symptoms
questionnaire, spirometry and histamine challenge testing.
The respiratory symptoms questionnaire was based on the
children’s version of the British Medical Research Council
(MRC) and American Thoracic Society’s respiratory symptom
survey questionnaire [25] and was supplemented with ques-
tions on smoking history.
Spirometry, including reversibility testing with salbutamol,
was carried out with a portable flow–volume meter (Microloop
IITM; MicroMedical Ltd, Rochester, UK) according to European
Respiratory Society (ERS) standards [26].
Histamine challenge testing was assessed by means of the
short procedure of the ERS’s standardised testing procedure
[27]. AHR to a nonspecific bronchoconstrictor, such as
histamine, has been recommended as an objective marker of
asthma-related airway lability in adolescents and young adults
[28]. All challenge tests were performed by certified lung
function technicians. Interpolation on a log-linear plot of
histamine concentration versus forced expiratory volume in one
second (FEV1) was used to determine the concentration of
histamine causing a 20% fall in FEV1 (PC20). When a subject
reported a respiratory tract infection or worsening of symp-
toms in the previous 6 weeks, the test was postponed until
o6 weeks after the end of the infection or the episode of
worsened symptoms.
Baseline allergic response to common allergens had been
assessed in 1989 by the Phadiatop test (Kabi Pharmacia
Diagnostics AB, Uppsala, Sweden) [29]. The test was con-
sidered positive when the ratio of a subject’s serum to the
reference serum was .1.
Information on physician-diagnosed asthma, acute bronchitis
before 1989 and family history of asthma was extracted from
the medical records in the CMR practices [30]. Subjects who
were unable or unwilling to take part in the study received a
short ad hoc questionnaire, with questions regarding physician-
diagnosed asthma, current medical treatment for asthma,
educational level, allergy and smoking behaviour. Subjects
were considered to be ‘‘symptomatic’’ at baseline and at
follow-up if they reported at least one of the following
symptoms: chronic cough, wheezing, chest tightness with
wheezing, or breathlessness (questions 1, 4, 5 and 6 of the MRC
questionnaire; table 1).
Study subjects were considered to have AHR at baseline or at
follow-up if the histamine PC20 was f8.0 mg?mL-1 [26].
Subjects who had an FEV1 value .1.646SD below predicted
were considered to have bronchial obstruction [26, 31].
A diagnosis of asthma was assigned, in agreement with the
definitions used in the 1989 study [19–22], if the subject fitted
TABLE 1 Items in the British Medical Research Council questionnaire [24] for which one or more positive responses defined
subjects as ‘‘symptomatic’’
Topic Question
Chronic cough Did you usually, at least 5 days?week-1, cough (when getting up or during the day
or night) during a period of o3 consecutive months?
Wheezing Have you had wheezing in your chest in the last 12 months?
Chest tightness with wheezing Have you had attacks of tightness with wheezing in your chest (attacks of asthma)
in the last 12 months?
Breathlessness Have you had breathlessness in the last 12 months?
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one or more of the following definitions: ‘‘symptomatic’’, in
combination with the presence of AHR and/or bronchial
obstruction with reversibility (definition 1); physician (GP or
pulmonologist)-confirmed diagnosis of asthma (definition 2);
and at least four recorded episodes of acute bronchitis in the
CMR database prior to the baseline assessment (definition 3).
In the current analysis, the third of these definitions was only
used for the baseline assessment in 1989, in order to identify
and exclude subjects with undiagnosed asthma in the study
cohort. All other subjects were labelled ‘‘nonasthmatic’’.
A positive family history was defined as at least one first-
degree relative of a participant having a physician-confirmed
diagnosis of asthma. Information on family history was
gathered from the CMR database [23].
Statistical analysis
Differences between participants and nonparticipants were
tested using Chi-squared and one-way ANOVA tests. The
main analysis was done with the data of subjects without an
asthma diagnosis at baseline who were assessed at baseline
and at follow-up, using a logistic regression model in which
AHR and the presence or absence of respiratory symptoms at
the baseline assessment were related to the diagnosis of asthma
(definition 1) at the follow-up assessment. This analysis was
adjusted for age, sex, allergy, positive family history of asthma,
and smoking history at the time of baseline assessment. An
additional analysis was performed using data from the CMR
database of all subjects who had been assessed at baseline. In
this analysis, the ‘‘physician diagnosis of asthma (definition 2)
since 1989’’ was the dependent variable. To take into account
the variable follow-up time of study subjects, Cox proportional
hazards analysis was performed.
RESULTS
Study population
For the follow-up study, 468 subjects (84.9% of the baseline
cohort) could be traced and were invited to take part. Figure 1
shows the flow of subjects through the study. In total, 83
subjects were lost to follow-up, of whom 77 had moved since
1989 and no current address was known. Due to significant
(nonrespiratory) health problems at the time of reassessment,
five subjects were excluded by their GP, and one subject had
died from a nonrespiratory cause.
Out of the 468 invited subjects, 343 (73.3%) responded and 206
were willing to participate in the follow-up study. Complete
follow-up data were only available for 199 subjects because
seven subjects were reluctant to have the histamine challenge
test. Out of the 137 subjects who were not willing to participate
in the follow-up assessment, 35 completed the short ad hoc
questionnaire.
Respiratory health status
For 199 subjects, respiratory symptoms and AHR were
reassessed at follow-up. Table 2 shows the characteristics of
included and not included subjects. The only statistically
significant difference between these two groups was allergy
status at baseline. Of the 199 subjects, 47 (23.6%) were
diagnosed with asthma before or at the baseline assessment.
The respiratory health reassessment of the 199 subjects
revealed airflow obstruction in two (1.0%) subjects. The
average FEV1 was 100% predicted (95% confidence interval
(CI) 98–102% pred). AHR (PC20,8 mg?mL-1) was shown by 53
(26.6%) subjects, and 87 (43.7%) subjects had respiratory
symptoms at follow-up. At follow-up, the geometric mean
(95% CI) of the PC20 of AHR subjects was 4.4 (3.7–5.0) mg?mL-1
histamine. Table 3 shows the presence or absence of AHR in
combination with presence or absence of symptoms at the
baseline assessment compared with the follow-up assessment.
Of 81 subjects with AHR at baseline, 33 (40.7%) also showed
AHR at follow-up, whereas of the 118 subjects without baseline
AHR, 98 (83.1%) again did not show AHR at follow-up. In
1989, 47 (23.6%) subjects had shown asymptomatic AHR, with
a geometric mean (95% CI) for PC20 of 5.6 (5.1–6.1) mg?mL-1.
Of these subjects, 33 had no AHR at reassessment in 2003–2004,
but seven had asymptomatic AHR and another seven had
symptomatic AHR. Of 199 subjects, 91 (45.7%) had the same
combination of AHR status and respiratory symptoms at
follow-up as at baseline.
Asthma diagnosis at follow-up
For 37 (18.5%) out of the 199 participants, the combination of
symptoms and airflow obstruction and/or AHR allowed an
asthma diagnosis at follow-up in 2003–2004: 31 participants
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FIGURE 1. Flow of study subjects between baseline assessment in 1989 and
follow-up assessment in 2003–2004. #: lost from follow-up; ": for 35 subjects,
information was collected with a short ad hoc questionnaire; +: no histamine
challenge test; 1: for 40 subjects, baseline allergy test was missing.
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had symptoms in combination with AHR, five participants had
symptoms in combination with AHR and airflow obstruction
and one participant had symptoms in combination with
airflow obstruction. For 19 (9.5%) out of the 199 subjects, this
was the first time asthma had been diagnosed, while the other
18 subjects had already been diagnosed with asthma before or
at the baseline study. Data from the CMR database for the
nonparticipants showed that GPs had diagnosed asthma in
three subjects and one subject reported physician-diagnosed
asthma in the short ad hoc questionnaire. A total of 23 new
cases with asthma were identified.
Association between asymptomatic AHR, allergy and
asthma diagnosed at follow-up
To assess whether there was an association between asympto-
matic AHR in adolescence and newly diagnosed asthma
(asthma definition 1) in adulthood, the final analysis was
limited to the subjects without an asthma diagnosis before or at
the baseline assessment (n5152; fig. 1). Of the 47 subjects with
asymptomatic AHR at baseline in 1989, eight (17.0%) were
classified as having asthma for the first time at follow-up in
2003–2004. Out of 76 subjects without AHR and without
respiratory symptoms at baseline, seven (9.2%) were classified
as having asthma at follow-up. Univariate analysis showed
that this difference was not statistically significant (Chi-
squared test, p50.20). In the logistic regression analysis, this
effect was adjusted for age, sex, allergy, family history of
asthma and smoking history (table 4). Again, having baseline
asymptomatic AHR was not a statistically significant risk
factor for asthma (odds ratio (OR) 2.20, 95% CI 0.64–7.62;
p50.21; subjects without symptoms and without AHR as
reference). A positive allergy test at baseline was associated
with having an asthma diagnosis at follow-up (OR 4.45, 95% CI
1.46–13.54; p50.009; negative allergy test as reference). Table 5
shows the rate of asthma diagnoses stratified by allergy status
and AHR status at baseline. No statistically significant
differences were found in these data. Changing the definition
of AHR to ,4 mg?mL-1 instead of ,8 mg?mL-1 histamine did
not significantly change the ORs, nor did it lead to a
statistically significant difference (results not shown).
Association between asymptomatic AHR and GP-diagnosed
asthma
Morbidity data from the CMR database were available for all
551 subjects of the initial study cohort, including all physician-
diagnosed asthma patients. The mean¡SD time of follow-up in
the CMR database from the baseline assessment was
8.6¡4.9 yrs. For 227 subjects there was a complete (14 yrs)
follow-up in the CMR. For the Cox proportional hazards
analysis, 417 subjects were available, since 134 subjects had
TABLE 2 Comparison between included and not included subjects for the follow-up analysis in 2003–2004
Total Included subjects Not included subjects p-value
Subjects n 551 199 352
Males 274 (49.7) 106 (53.3) 168 (47.7) 0.21
Age yrs 29.8¡3.2 30.1¡3.2 29.6¡3.2 0.10
Baseline assessment#
Asymptomatic"
No AHR 205 (37.2) 76 (38.2) 129 (36.6)
AHR 133 (24.1) 47 (23.6) 86 (24.4) 0.96
Symptomatic"
No AHR 114 (20.7) 42 (21.1) 72 (20.5)
AHR+ 99 (18.0) 34 (17.1) 65 (18.5)
Asthma diagnosis1 134 (24.3) 47 (23.6) 87 (24.7) 0.77
Allergice 163 (33.1) 76 (41.1) 87 (28.3) 0.004
Data are presented as n (%) or mean¡SD, unless otherwise stated. AHR: airway hyperresponsiveness. #: in 1989; ": according to questionnaire; +: all these subjects were
classified as having asthma according to the criteria used in the present study; 1: diagnosis by general practitioner or at baseline assessment; e: Phadiatop test during
baseline assessment, available for 492 (89%) of the subjects in the baseline cohort.
TABLE 3 Presence or absence of airway
hyperresponsiveness (AHR) in combination with
presence or absence of symptoms at baseline
compared with follow-up assessment
Follow-up assessment#
Asymptomatic Symptomatic Total
No AHR AHR No AHR AHR"
Baseline assessment+
Asymptomatic
No AHR 51 (67.1)1 3 (3.9) 15 (19.7) 7 (9.2) 76 (100)
AHR 24 (51.1) 7 (14.9)1 9 (19.1) 7 (14.9) 47 (100)
Symptomatic
No AHR 14 (33.3) 3 (7.1) 18 (42.9)1 7 (16.7) 42 (100)
AHR" 6 (17.6) 4 (11.8) 9 (26.5) 15 (44.1)1 34 (100)
Total 95 (47.7) 17 (8.5) 51 (25.6) 36 (18.1) 199 (100)
Data are presented as n (%). #: in 2003–2004; ": all these subjects were
classified as having asthma according to the criteria used in the present study;
+: in 1989; 1: subjects with the same AHR status in combination with respiratory
symptoms at baseline and follow-up.
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already been diagnosed with asthma before (n524) or at
(n5110) the baseline assessment and these subjects were
excluded from further analyses. Since the baseline assessment,
seven subjects had been diagnosed with asthma by their GP for
the first time (asthma definition 2), of whom four were also
diagnosed with asthma at the follow-up assessment. Again,
having asymptomatic AHR at baseline was not a statistically
significant predictor of being assigned an asthma diagnosis by
a GP compared with subjects without symptoms and without
AHR (hazard ratio 1.6, 95% CI 0.4–6.5; p50.50).
DISCUSSION
At the end of the 14-yr follow-up of study subjects, a de novo
diagnosis of asthma was established in 23 subjects, but no
relationship was found between asymptomatic AHR in adoles-
cence and a diagnosis of asthma in adulthood. Furthermore,
asymptomatic AHR turned out not to be a constant factor from
adolescence to adulthood in the present general population
sample, as only 46% had the same AHR status in combination
with respiratory symptoms at follow-up as at baseline.
Strengths and limitations
To the current authors’ knowledge, the present study is the
first to investigate the relationship between asymptomatic
AHR in adolescents and clinically diagnosed asthma in
adulthood with the present length of follow-up and study
population size. In total, 199 subjects had their respiratory
status assessed twice with a time interval of 14 yrs. In addition,
analysis of asymptomatic AHR in relation to physician-
diagnosed asthma was possible in all 551 subjects from the
1989 study cohort, with an average follow-up of 8.6 yrs. This
enabled assessment of the predictive value of asymptomatic
AHR for asthma in this population.
There are, however, also some limitations to the present study. Not
all subjects from the baseline assessment group could be traced.
Since, at the time of the first assessment study, participants were
adolescents who lived with their parents, 14 yrs later most of
them had moved to live on their own and were no longer
registered in their original general practices. No differences
were found in age, sex or respiratory status between the study
participants, the nonparticipants and the original 1989 study
population, but selective participation can not be fully ruled out.
Although asymptomatic AHR is thought to be associated with a
higher risk for development of asthma [9–11], it is still unknown
whether asymptomatic AHR precedes the development of
asthma and is a risk factor preceding asthma, is a condition
consistent with a very mild state of asthma that may develop
into clinically more manifest asthma, or is a coincidental clinical
characteristic.
Several studies have been conducted in order to elucidate the
relationship between asymptomatic AHR and asthma.
However, most of these studies followed their subjects for a
short period of time and had smaller, selected patient samples
[9–12, 16, 17, 32, 33]. LAPRISE and BOULET [11] reported a 3-yr
follow-up study in 60 subjects with a mean age of 32 yrs:
30 subjects with asymptomatic AHR for methacholine and 30
normo-responsive subjects. Subjects with asymptomatic AHR
had a larger increase in airway responsiveness and frequency
of development of asthma symptoms than the normorespon-
sive subjects. Nevertheless, allergen exposure in sensitised
subjects at the time of the study and genetic predisposition
seemed to be the main risk factors for the development of
symptomatic asthma. ZHONG et al. [10] reported that 20% of 50
asymptomatic students with AHR developed asthma during
2 yrs of follow-up. In contrast with these findings, the present
study found that asymptomatic AHR in adolescence is not a
risk factor for the development of asthma in adulthood. This is
in line with DE GOOIJER et al. [16] and AN˜ı´BARRO et al. [17], who
found no correlation between asymptomatic AHR and asthma
development. AN˜ı´BARRO et al. [17] followed 15 school-aged
children with rhinoconjunctivitis for 4 yrs and found that
neither the presence nor the degree of AHR for methacholine
TABLE 4 Results of multivariate logistic regression
analysis, in which airway hyperresponsiveness
(AHR) and the presence or absence of
respiratory symptoms at the baseline
assessment were related to a new diagnosis of
asthma at the follow-up assessment#
Covariate OR 95% CI p-value
Asymptomatic, AHR" 2.20 0.64–7.66 0.21
Symptomatic, no AHR" 2.06 0.50–8.52 0.32
Sex+ 1.49 0.47–4.69 0.50
Positive family history1 0.70 0.08–6.63 0.76
Smoking in 1989 0.53 0.09–3.00 0.47
Age 0.96 0.79–1.17 0.66
Allergye 4.45 1.46–13.54 0.009
The effect was adjusted for age, sex, allergy, family history of asthma and
smoking history at the time of the baseline assessment; n5140. OR: odds ratio;
CI: confidence interval. #: definition 1; ": subjects without symptoms and
without AHR as reference; +: females compared with males; 1: at least one first-
degree relative with asthma; e: subjects with negative Phadiatop test as
reference.
TABLE 5 Breakdown of asthma diagnoses at follow-up
into categories of allergy and airway
hyperresponsiveness (AHR) status at baseline
Asthma diagnosis at
follow-up#
Subgroup total
No allergy at baseline"
Asymptomatic, no AHR 3 (6.1) 49
Asymptomatic, AHR 1 (3.8) 26
Symptomatic, no AHR 2 (12.5) 16
Total 6 (6.6) 91
Allergy at baseline",+
Asymptomatic, no AHR 2 (11.8) 17
Asymptomatic, AHR 7 (38.9) 18
Symptomatic, no AHR 3 (21.4) 14
Total 12 (24.5) 49
Data are presented as n (%) or n. #: in 2003–2004, asthma definition 1; ": in
1989; +: positive Phadiatop test. No statistically significant differences were
found in these data.
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predicted development of asthma. DE GOOIJER et al. [16]
reported that mild AHR for histamine in childhood was not
a risk factor for respiratory symptoms in young adulthood.
This was investigated in a 27-yr follow-up study in 60 children
aged 8–11 yrs. The inconsistency of these findings regarding
the relationship of AHR and asthma may be explained by
differences in subject age, but may also be explained by the
multicausality of AHR and asthma. AHR, as well as asthma,
can probably be induced or enhanced by lower respiratory
tract infections in early childhood, exposure to tobacco smoke
and atopic status. For example, atopy is a known risk factor for
asthma [34]. In the present study, the presence of allergy in
adolescence was indeed a risk factor for the development of
asthma. This suggests that the presence of allergy is more
important than asymptomatic AHR when predicting future
asthma.
In the present study population, AHR status was not consistent
over the 14-yr observation period. This supports the view of
AHR being a dynamic process that can vary over time [15, 35]
rather than a static characteristic of the airways. AHR can
appear or become worse after exposure to various environ-
mental stimuli, such as exposure to tobacco smoke or the
occurrence of respiratory tract infections. Conversely, AHR can
also decrease, either spontaneously or after anti-inflammatory
treatment. The inconsistency of AHR status in the current
study subjects has probably been caused by a combination of
these mechanisms. The estimate of 18.5% for the period
prevalence of asthma in the cohort is quite similar to the
figure of 21% that was recently reported for young adults from
another Dutch birth cohort [34].
A final point that warrants discussion is the appropriateness of
using histamine as a measure of AHR. Although early studies
have reported that all patients with asthma are hyperreactive to
histamine [3], other physiological stimuli, such as, for instance,
adenosine 59-monophosphate, may be more sensitive indicators
of AHR and might have better served the purposes of the
present study. However, in 1989, when the study was started,
the position of adenosine was not yet established, and assessing
AHR with the use of histamine was the standard in the
Netherlands and across Europe. Moreover, AHR to histamine is
still recommended as an objective marker of asthma-related
airway lability in adolescents and young adults [28].
Clinical implications
The present study does not close the book on asymptomatic
AHR as a risk factor for asthma. However, before screening for
asymptomatic AHR can be recommended, it is important to
have solid evidence that screening for asymptomatic AHR
leads to a positive effect on the asthma burden, such as
prevention of airway remodelling [36]. BOULET [15] has
suggested that asymptomatic AHR could be used to identify
subjects with a higher risk of developing asthma, in order to
subsequently provide these patients with treatment to prevent
symptoms of asthma. However, on the basis of the current
study, it can be concluded that screening for asymptomatic
AHR in a respiratory symptom-free population during
adolescence is not likely to be a valuable action to identify
subjects at risk of developing asthma. The presence of allergy
in adolescence is probably a more important predictor of
asthma in this respect.
Conclusion
Asymptomatic airway hyperresponsiveness in adolescence is
not a risk factor for the development of asthma in adulthood.
The presence of allergy in adolescence, however, seems to
predict the development of asthma. Furthermore, asympto-
matic airway hyperresponsiveness turned out to be an
inconsistent characteristic from adolescence to adulthood after
14 yrs of follow-up. On the basis of the present study,
screening for airway hyperresponsiveness in adolescents to
detect subjects at risk of asthma cannot be recommended;
however, in adolescents with allergy, physicians should be
aware of the potentially increased risk of developing asthma
while growing to maturity.
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rhinitis also have  asthma.3;4 a growing 
number of studies suggest that allergic 
rhinitis and allergic asthma are mani-
festations of the same disease entity: 
‘one airway, one disease’.5;6 Still, not all 
patients with allergic rhinitis eventually 
present with asthma and not all pa-
tients with asthma have allergic rhini-
tis. therefore,  prospective studies are 
required to assess the risk of asthma in 
patients with allergic rhinitis.7 .
although a causal  relationship is 
suspected, there are only a few lon-
gitudinal studies that confirm this 
widespread notion.8-12 most of these 
studies were based on selected popu-
lations, or  consisted of small numbers 
with a high likelihood of selective inclu-
sion. allergic rhinitis and asthma are 
frequent disorders in childhood and 
adulthood, often encountered  in pri-
mary care. however, we are not aware 
of any prospective studies in primary 
care,  with physician diagnosed allergic 
rhinitis and asthma. therefore the aim 
of this study was to assess prospec-
tively whether a diagnosis of allergic 
rhinitis is a risk factor for the diagnosis 
of asthma in a large primary care popu-
lation. 
MeThods
study design 
we performed a historic cohort study 
in a database with  complete life-time 
morbidity data that had been recorded 
at the time of intial diagnosis,  in four 
general practices. we assessed the risk 
of physician diagnosed asthma in pa-
tients with physician diagnosed allergic 
rhinitis compared  to subjects without 
a diagnosis of allergic rhinitis. 
the morbidity data were taken from 
the Continuous morbidity registration 
(Cmr) , the academic general practice 
network of the radboud university nij-
megen medical Centre, department 
of primary and Community Care, the 
netherlands. the Cmr exists since 
196713.  all general practitioners’(gp) 
of these practices enter their diagno-
ses (morbidity)  of each episode of care, 
uniformly coded and registered. in the 
structure of the dutch health care sys-
tem, everyone is listed with a general 
practice and can get access to health 
care only through that practice..  the 
practice population of Cmr (approxi-
mately 35,500 patients) , is in sociode-
mographic characteristics comparable 
to  the dutch population at large 13-17 
. the  population is relatively stable13 
with an annual change-over rate of 5% 
of patients. each  patient  is assigned 
a unique identifier number,  to allow 
recording  and analysis of morbid-
ity on an individual basis (medical life 
histories). the database also provides 
individual-specific information on age, 
gender, socioeconomic status (SeS), 
and the calendar dates the patient 
entered and (if applicable) left the 
practice. as the gp functions as gate-
keeper and specialists report back to 
the gp after a referral, the Cmr data-
base also includes diagnoses made by 
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Is physician diagnosed  
allergic rhinitis  
a risk factor for the  
development of asthma?
ABsTRACT: Background: There is strong evidence that there is a relationship between allergic 
rhinitis (AR) and asthma, but it is unclear whether there is a causal  relation between asthma and AR. 
Objective: The aim of this study was to assess prospectively whether allergic rhinitis is a risk factor 
for the diagnosis of asthma in a large primary care population. 
Methods: We performed a historic cohort study of life-time morbidity that had been recorded pro-
spectively since 1967 in four general practices. Two groups of subjects were selected :1) patients 
with diagnosis of allergic rhinitis, 2) a control group matched using propensity scores. We assessed 
the risk of physician-diagnosed asthma in patients with physician-diagnosed allergic rhinitis com-
pared to subjects without a diagnosis of  allergic rhinitis (controls).  
Results: The study population consisted of 6491 subjects (n= 2081 allergic rhinitis patients). Average 
study follow-up was 8.4 years.  In AR patients the frequency of newly diagnosed asthma was 7.6% ( 
n= 158) compared to 1.6% (n= 70) in controls (p<0.001). After adjusting the effect of AR on asthma 
diagnosis for registration time, age, gender, eczema and socioeconomic status, having AR was a sta-
tistically significant risk factor for asthma (hazard ratio: 4.86 , p<0.001, 95% CI: 3.50-6.73, controls 
as reference).
Conclusion: A diagnosis of AR was an independent risk factor for asthma in our primary care study popula-
tion. Having physician diagnosed AR increased the risk almost five fold for a future asthma diagnosis.
Abbreviations:
95% CI: 95% confidence interval
AR: allergic rhinitis
CMR: Continuous Morbidity Registration
GP: General practitioner
ICHPPC: International Classification of Health Problems in Primary Care
Sd: standard deviation
SES: Socio Economic Status
InTRoduCTIon
there is  evidence of a relationship 
between allergic rhinitis and asthma, 
but until now the nature of this link re-
mains a subject of debate.1;2 Cross-sec-
tional studies have shown that allergic 
rhinitis and asthma frequently coexist. 
up to eighty percent of all asthma pa-
tients have concomitant allergic rhinitis 
and over 20% of patients with allergic 
Lotte van den Nieuwenhof, Tjard Schermer, Yvonne Bosch, Jean Bousquet, Yvonne Heijdra, Hans Bor, Wil van den 
Bosch, Chris van Weel. Submitted
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Figure 1. Flow study population
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Follow-up
follow-up of patients in the ar group 
started at the date ar was diagnosed. 
for each control subject a dummy 
‘date of diagnosis’ was used that 
equaled the date of ar diagnosis of the 
ar patient they were matched to. this 
fictious ‘date of diagnosis’ meant that 
controls had to be present in the Cmr 
database at the same moment in time 
when an ar diagnosis was given to the 
matched ar patient (for instance, a 
patient diagnosed with ar in July 1987 
was matched to a control subject that 
was also present in the Cmr database 
in July 1987). this accounted for any 
possible time period effect in diagnosis 
of ar and asthma. the dummy ‘date of 
diagnosis’ marked the start of the ob-
servation period for the controls. fol-
low-up ended (i.e. data were censured) 
both for ar patients and controls at the 
date asthma had been diagnosed, the 
date the patient left the Cmr practice, 
or the selected date of study termina-
tion ((January first 2006), whichever 
occurred first. 
statistical analysis
the data were analyzed with SpSS 12.0 
for windows and SaS 9.1.3.  in order to 
form a control group that matched the 
group of ar patients, propensity score 
matching24 was used. a logistic regres-
sion model was used first to predict the 
propensity of having allergic rhinitis us-
ing individual characteristics as gender, 
age, SeS, general practice and date of 
diagnosis. after balancing covariates in 
the propensity score model, a greedy 
matching algorithm was used with a 
1:2 matching from best to next-best 
for the outcome model. Best matches 
were defined as those with the highest 
digit match (0.00001) on the propen-
sity score. the algorithm proceeded 
sequentially to the lower digit match. 
the lowest allowable digit match was 
0.1. after the first match for each ar 
patient had been selected, the same 
procedure was used to match controls 
that were not previously matched in 
order to get a 1:2 matching rate. to ex-
amine the extent to which the match-
ing procedures resulted in comparable 
samples in terms of individual charac-
teristics, chi square tests were used 
for categorical variables and Student t-
tests for continuous variables. p-values 
used in these analyses were two-tailed 
and differences with p-values of <0.05 
were considered statistically signifi-
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any other physician after referral (for 
this study: respiratory diagnoses made 
by chest physicians, internists and pe-
diatricians). when a patient leaves the 
practice, the morbidity registration 
terminates. the gps of the four prac-
tices meet regularly to discuss clas-
sification and coding issues to assure 
uniformity and accuracy. these factors 
allow reliable patient tracking and solid 
opportunities for studying disease lon-
gitudinally15-17. 
Morbidity data and  
diagnostic criteria
Since the start of the Cmr the same 
standardized classification system has 
been used to record morbidity. the 
classification system has been adapted 
over the years to definitions of the 
international Classification of health 
problems in primary Care (iChppC)-2 
18 and to other primary care references 
(for this study: the dutch College of 
general practitioners’ guidelines of 
asthma 19-21 and allergic rhinitis22). SeS 
is defined according to profession and 
education level based on the dutch 
Standard Classification of occupations, 
1992 23(ref).
Morbidity definitions  
and subject selection
the definitions used in the Cmr 
practices to record allergic rhinitis 
(ar), asthma and eczema are based 
on iChppC-2 18  and are shown in 
table 1.  using these definitions, two 
groups of subjects were selected 
from the Cmr database:
1 allergic rhinitis (ar) group: all the patients with a diagnosis of ar in 
the Cmr database in the period be-
tween the first of January 1967 until 
the first of January 2006. patients 
older than 50 years at the time of 
their initial diagnosis of ar were ex-
cluded in order to avoid misdiagnosis 
of asthma for Copd. 
2 Control group(controls): subjects without a recorded diagnosis 
of ar in the database, matched for 
age, gender, socioeconomic status, 
general practice in which they were 
listed and date of diagnosis.  Subjects 
with an asthma diagnosis at start of 
the follow-up were excluded for the 
prospective analysis as these patients 
already had asthma and therefore 
could not develop asthma during the 
follow-up.
Allergic rhinitis (r97)
 pruritic exudative lesion with/without lichenification 
over face and neck, wrists and hands, chest, back of 
knees and front of elbow.
Asthma (r96)
Eczema, atopic (S87)
recurrent episodes of reversible acute bronchial obstruc-
tion with wheeze/dry cough; or diagnostic test meeting 
currently accepted criteria for asthma
includes hay fever and nasal allergy
Table 1 Definitions based on International Classification  
of Health Problems in Primary Care (ICHPPC)-2 classification.1
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Figure 1. Flow study population
AR patients
n=2279 (33.3%)
Control subjects
n=4558(66.7%)
CMR database 
1967-2006 
Start of follow up
Total study population n=6491*
Asthma prior to start 
follow up
n=148
(3.2% of control 
subjects
67.9% of the 218 
asthma patients in 
control group)
Asthma prior to 
follow up
n=198
(8.7% of AR patients
55.6% of the 356 
asthma patients in 
AR group)
New physician-diagnosed asthma
n=158 (7.6%)**
(44.4% of the 356 asthma patients 
in AR group)
New physician-diagnosed asthma
n=70 (1.6%)**
(32.1% of the 218 asthma patients 
in control group)
Control subjects: n=4410 
(67.9% of total study population)
AR patients: n=2081 
(32.1% of total study population)        
n=6837
* Included in main analysis, **p<0.001
Figure 2. Age range of study population (n=6491)
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the controls (figure 2).
table 2 shows the characteristics 
of the ar patients and the controls. 
Compared to the controls, ar patients 
had a slightly higher SeS and had sta-
tistically significant more diagnoses of 
atopic eczema (19.3% versus 13.0%, 
p<0.001). there were no other statisti-
cally significant differences. the mean 
study follow-up of the total population 
was 8.4 years (sd 7.7). 
Association between  
allergic rhinitis and 
asthma
Cross sectional analysis of the data 
showed that a total of 574 (8.3%) pa-
tients were diagnosed with asthma 
ever (before and after start of follow-
up), 15.6% (n=356) of the ar group 
and 4.8% (n=218) in the control group 
(p<0.001). of the 356 patients in the 
ar group that were diagnosed with 
asthma, 52.8 % (n=158) were diag-
nosed after the diagnosis of ar. of the 
218 controls that were diagnosed with 
asthma 32.1% (n=70) were diagnosed 
after the start of follow-up. 
after start of follow-up, the rate of 
newly diagnosed asthma in ar patients 
was 7.6% ( n=158) compared to 1.6% 
(n=70) in controls (figure 1). Chi-square 
testing showed that this difference 
was statistically significant (p<0.001). 
for patients with new physician-diag-
nosed asthma, the mean duration be-
tween start of follow-up and diagnosis 
of asthma was 5.7 years for ar patients 
and 5.8 years for controls (p=0.9).
the results of the multivariable Cox 
proportional hazard analysis are shown 
in table 3. having ar was a statisti-
cally significant risk factor for asthma 
(hazard ratio: 4.86, 95%Ci: 3.50-6.73, 
cant. a chi square test was also done 
to compare the percentage asthma pa-
tients in the ar group and the control 
group cross-sectionally.
to take into account the variable fol-
low-up time in the study population, 
Cox’s proportional hazard analysis was 
used to assess the risk on a diagnosis 
of asthma in patients with ar relative 
to controls. the Cox proportional haz-
ard model takes maximum advantage 
of each subject’s available data even 
when subjects were tracked for differ-
ent lengths of time, and the outcome 
of interest might not have occurred. 
the multivariable Cox’s proportional 
hazard model adjusted for the effects 
of age, gender, eczema, socioeconomic 
class and general practice. we used 
‘physician diagnosed asthma since 
start of follow-up’ as the dependent 
variable. p values as well as 95% con-
fidence intervals (95% Ci) were calcu-
lated for the hazard ratio’s. 
ResuLTs
study population
we identified 2279 patients with al-
lergic rhinitis in the Cmr database. 
every ar patient was matched by the 
propensity score matching procedure 
to two controls which lead to a control 
group of 4558 subjects. the total study 
population consisted therefore of 6837 
subjects. of this group 346 patients 
had a diagnosis of asthma prior to the 
start of follow-up (198 ar patients 
and 148 controls). as these patients 
already had asthma and therefore had 
no chance on developing asthma dur-
ing the follow-up, they were excluded 
from the prospective analysis. the ex-
clusion of this group led to a final study 
population of 6491 subjects (See figure 
1).  the mean age at the start of follow-
up was 25.1 years (sd 11.8, range 0-88 
years) for the ar patients and 25.2 
years (sd 12.6, range 0-60 years) for 
FeMaLe
Age In yeArs (sD)**
SeS: LoW 
ses: mIDDle
ses: HIgH
Follow-uP PerIoD 
In yeArs (sD)
eCzemA*
AR: AllERGIC RHInITIS / SES: SOCIAl ECOnOMIC STATuS / Sd: STAndARd dEvIATIOn 
* nOT InCludEd In THE PROPEnSITy SCORE MATCHInG PROCEduRE / ** AT START Of fOllOW-uP
Table 2  Characteristics of allergic rhinitis patients and controls. 
Figures are % (n) unless stated otherwise.
Total 
(n=6491)
AR patients 
(n=2081)
controls 
(n=4410)
P-value
55.2 (3584) 55.3 (1151) 55.1 (2432)
25.2 (12.3) 25.1 (11.8) 25.2 (12.6) 0.71
39.7 (2582) 38.1 (793) 40.5 (1787)
45.4 (2949) 45.6 (949) 45.3 (1997) 0.04
14.9 (965) 16.3 (339) 14.2 (626)
15.1 (978) 19.3 (402) 13.1 (576) <0.001
8.4 (7.6) 8.4 (7.5) 8.5 (7.6) 0.6
0.9
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as far as we are aware this is the first 
study that prospectively investigated 
the relationship between physician 
diagnosed ar and physician diagnosed 
asthma in a primary care population 
with such a wide age-range, such a 
large study population size and this 
length of follow-up (over eight years 
of follow-up of 6496 subjects, among 
which 2279 ar patients). as ar and 
asthma are generally diagnosed and 
treated in primary care, it is impor-
tant to assess their relationship in this 
population. the dutch health care sys-
tem is well-suited for primary care re-
search, since all patients are registered 
with a  gp who is the starting point of 
all health  care  (gp is ‘gate keeper’), 
with specialist care only available af-
ter  referral.  everyone is insured by a 
single payer source and the population 
is relatively stable. these factors allow 
reliable patient tracking of  diseases 
over time.
this study used physician diagnosed 
ar and asthma that had been re-
corded at the time of presentation 
by the patient. the strength of this  is 
– compared to questionnaire-based 
surveys – that this includes  a profes-
sional clarification and interpretation 
of  patients’ perceived signs and symp-
toms. the diagnostic criteria of ar and 
asthma in the Cmr have been defined 
in line with international criteria19;21;22. 
the gps of the Cmr network meet reg-
ularly to discuss classification and cod-
ing issues, and earlier studies have es-
tablished a high accuracy of diagnosis 
of a variety of clinical conditions16;25. 
for that reason we are confident that 
the quality of the recorded data in this 
study was at least as good as that of 
questionnaire-based studies.
ar can be defined using ‘subjective’ 
symptoms (blocked or runny nose, 
sneezing, itchy nose), or using objective 
findings (e.g. skin prick tests or mea-
surement of ige specific antibodies) or 
a combination of both objective and 
subjective findings. in this study most 
ar diagnosis are based on subjective 
symptoms. although results of skin 
prick tests and ige can be better repro-
duced, it measures sensitization, not 
necessarily the presence of relevant 
illness26-28.  it has been reported that 
the attributable fraction of ige-medi-
ated allergy in patients with a diagno-
sis of allergic rhinitis by questionnaires 
is slightly over 50%27 and non-allergic 
rhinitis was reported to account for 30 
to 70% of patients with chronic or per-
sistent rhinitis 26;29. nevertheless, most 
studies on ar have been based only 
on an assessment of symptoms4;9;11;12;3 
0using a questionnaire. recall bias 
and patients’ misinterpretation of 
questions can  influence the results of 
questionnaire studies31-33. probably in 
epidemiologic studies, there is an over-
estimation of allergic rhinitis when us-
ing questionnaires only.  
as ar is a relatively common disorder 
with available over-the-counter medi-
cation many patients will first try to 
solve their problems their selves before 
consulting a physician for their symp-
toms.34 therefore it is possible that a 
part of the ar patients in the general 
population did not consult their gp and 
were consequently not included in this 
study  – in particular patients with mild 
symptoms. this means that it can not 
be excluded that some  control sub-
jects did in fact suffer from  (mild) ar . 
we used the propensity score match-
ing procedure24 to form a control 
group. it was possible to match every 
ar patient to two controls. however, 
as with matching on individual charac-
teristics, this method can only reduce 
bias in the measured characteristics 
(age, gender, social economic status, 
p<0.001, , controls as reference). this 
difference in risk is depicted in figure 
3. in time, the cumulative hazard of ar 
patients for development of asthma 
increased statistically significant com-
pared to the controls. atopic eczema 
had no statistically significant effect on 
the risk for asthma but age did have a 
small statistically significant effect on 
the risk of developing asthma in the 
future: the younger a subject was at 
the start of the observation period, 
the higher the risk of being assigned an 
asthma diagnosis by their gp (hazard 
ratio 0.98, 95%Ci 0.97-0.99, p=0.001, 
one year older age as reference).
dIsCussIon
in this  primary care study we found 
that a physician diagnosis of allergic 
rhinitis(ar) is an independent risk factor 
for a future diagnosis of asthma. having 
ar increased the risk almost five-fold for 
an asthma diagnosis later in life.
AllergIC rHInItIs
eCzeMa
AllergIC rHInItIs * 
eCzeMa
age aT STaRT oF 
STudY
ses mIDDle
ses  HIgH
#fOR A (nEW) PHySICIAn dIAGnOSEd ASTHMA
Table 3 results of Cox proportional hazard analysis (n=6491). the hazard on a diagnosis 
of asthma is adjusted for registration time, allergic rhinitis, eczema, gender, age at start 
of study and socioeconomic status (ses). 
Variables in the cox’s  
proportional hazard model
Reference 
category
Hazard 
ratio#
95% CI P-value
Control subject 4.86 3.50-6.73 <0.001
no eczema 1.61 0.92-2.82 0.10
no rhinitis * 
eczema 
0.88 0.46-1.70 0.71
one year older 0.98 0.97-0.99 0.001
SeS low 1.05 0.80-1.38 0.72
SeS low 0.75 0.47-1.19 0.22
X-aXiS: fOllOW-uP In yEARS
y-aXiS: CuMulATIvE HAzARd
_____  = case
--------- = control
Figure 3. Hazard plot of Cox proportional 
hazard function of allergic rhinitis patients 
and controls regarding the outcome: physi-
cian diagnosed asthma. 
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patients with ar were diagnosed with 
asthma, our findings imply that pa-
tients who are diagnosed with ar de-
serve extra attention from their gp re-
garding possible coexistence of asthma 
or its development in the  years after 
diagnosis of ar .
in conclusion, a diagnosis of ar is an 
independent risk factor preceding the 
diagnosis of asthma in this primary 
care population. having a physician di-
agnosed ar increased the risk almost 
five fold for an asthma diagnosis in the 
future.
general practice and date of ar diag-
nosis). the controls differed statisti-
cally significantly from the ar patients’ 
socioeconomic status characteristics. 
however, these differences were small 
and not clinically relevant and adjusted 
for age, gender, social economic sta-
tus, a history of eczema and general 
practice, the risk for asthma in subjects 
with ar still increased substantially.
Several studies have been conducted 
to elucidate the relation between ar 
and asthma. most studies reported 
findings in line with ours in showing 
an increased risk of asthma in subjects 
with ar. however, most of these stud-
ies were difficult to translate to the 
longitudinal observations of patients 
in general practice, as they were cross-
sectional in design, followed up their 
subjects only for a short period of time 
or were not based on a primary care 
population with this age range9;10;30;35. 
Shaaban et al.8 carried out a longitudi-
nal population-based study in 14 coun-
tries. they reported that allergic rhini-
tis increased the risk of asthma almost 
four fold, but also non-allergic rhinitis 
significantly increased this risk. their 
population did not include children 
and given the high prevalence of ar 
and allergy in childhood, the follow-up 
from childhood onwards is in our view 
a strength of our study. Burgess et al 
only included children. in this study 7 
year old children were followed-up un-
til the age of 44 years. in that  study, 
self reported ar increased the risk of 
asthma after childhood.36  Settipane 
et al.9 carried out a 23-year follow-up 
study of college students (predomi-
nantly males) aged 18-19 years and 
found almost a threefold increase on 
asthma risk.  huovinen et al.30 followed 
up a cohort of twins  during 15 years 
and assessed whether the participants 
had ar or not by questionnaire. they 
found an asthma incidence rate ratio 
of 4.3 for men and 6.0 for women. Lin-
neberg et al10 found that ar predicted 
development of allergic asthma, but 
their definition only included asthma 
symptoms provoked by allergens. pors-
bjerg et al11 found that presence of ar 
established  by questionnaire did not 
increase the risk on asthma. they fol-
lowed up their 291 participants (atopic 
as non atopic subjects) for 12 years. an 
univariate analysis showed no statisti-
cally significant or of 1.7 (95% Ci 0.7-
3.9). these findings are in line with part 
of the reported findings by plaschke 
et al.12 who found that non atopic 
subjects (assessed by skin prick test-
ing) did not have an increased risk for 
asthma, whereas atopic subjects had 
(or 5.7,95% Ci 2.2-14.6).  
next to the epidemiologic evidence 
of the relation of ar and asthma, there 
are also  pathophysiologic data to link 
asthma and rhinitis. anatomically, the 
nose and lungs are closely related and 
rhinitis and asthma are both manifes-
tations of an inflammatory process 
within this continuous airway sys-
tem.2;2;37;38  until now it is unknown 
whether ar is an early clinical mani-
festation of allergic disease in atopic 
subjects which will later progress into 
asthma, or whether ar itself is an ac-
tual risk factor for asthma. in this study 
we found that 44% of asthma patients 
were diagnosed with asthma after the 
diagnosis of ar and 56% before or at 
the time of the diagnosis of ar. this 
suggests that there is a connection 
between ar and asthma but not a pro-
spective one in every case.
Clinical implications
our findings show that patients with 
ar had a 4.9 fold  increased risk of 
subsequently developing asthma com-
pared to controls. even though not all 
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ABBRevIATIons
aCQ: asthma Control Questionnaire
FP: family physician
gina: global initiative for asthma
roC curve: receiver operating Charac-
teristic curve
InTRoduCTIon
asthma is a common chronic respi-
ratory disease with a prevalence of 
5% of the world’s population, and this 
prevalence is still rising.1,2 By achiev-
ing optimal control of asthma, the 
risk of life-threatening exacerbations 
and severe morbidity can be greatly 
reduced. therefore, achieving respi-
ratory symptom control is one of the 
main targets in the management of 
patients with asthma. the global ini-
tiative for asthma (gina) guidelines3 
specify a number of goals for the long-
term management of asthma. among 
these are minimal chronic symptoms 
-including nocturnal symptoms- mini-
mal need for as-required β2-agonists 
and no limitations to daily activities. 
these treatment objectives are also 
pursued in (primary care) guidelines 
like the dutch College of family physi-
cians guideline for asthma.4 
however, despite the availability of 
highly effective pharmacotherapy, 
poorly controlled asthma is reported 
in up to 70-95% of patients in western 
europe and the asian-pacific region.5,6 
among other factors, poor compliance 
and knowledge of asthma medication 
and poor adherence towards regular 
control visits are explanations for this 
suboptimal control.7,8 there are also 
indications that patients as well as 
physicians overestimate the level of 
asthma control.5,6 therefore, a good 
and simple method to identify those 
asthma patients who are inadequately 
controlled would be welcome to sup-
port health care professionals in decid-
ing which patients are particularly in 
need of their attention. unfortunately, 
even though asthma control is of grow-
ing concern to clinicians and research-
ers, there is currently no gold standard 
to classify patients according to their 
level of asthma control. Because of 
this, the asthma severity classification 
in the gina guideline3 is often used to 
define asthma control.9,10
in the netherlands, all inhabitants are 
registered with a family physician (fp), 
and access to health care services is 
largely coordinated by the fp. as a con-
sequence, the majority of dutch pa-
tients with asthma are treated by fps, 
so, particularly in family practice, an 
adequate method to detect patients 
with poor asthma control is very rel-
evant. Because of the time restraints 
health care professionals generally 
have, patients with apparent poor 
asthma control could be prioritized for 
extra attention by their fp or other pri-
mary care professionals. 
an increase of bronchial symptoms 
has been reported to be an essential 
part of true loss of asthma control11 
and several questionnaires have been 
developed to measure asthma symp-
toms.12,13 however, these question-
naires have been developed and used 
in selected patients and in specific 
settings - mostly in clinical studies 
– so there is a need to explore whether 
these instruments can be used in pri-
mary care to trace patients with un-
controlled asthma. therefore, the aim 
of the current study was to explore 
whether fps can differentiate between 
patients with controlled and uncon-
trolled asthma symptoms by using a 
short questionnaire that measures the 
level of asthma symptom control. the 
shortened version of the asthma Con-
trol Questionnaire© (aCQ) developed 
by Juniper et al.13-15 was selected for 
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Can the Asthma Control 
Questionnaire be used 
to differentiate between 
patients with controlled 
and uncontrolled asthma 
symptoms? A pilot study.
ABsTRACT: 
Background: A substantial number of adult patients with asthma are inadequately controlled de-
spite the availability of effective asthma treatment. Patients and physicians seem to overestimate 
the level of asthma control. The current study explores whether valid differentiation is possible 
between asthma patients with controlled and uncontrolled asthma symptoms, on the basis of the 
Asthma Control Questionnaire (ACQ).
Methods. In this multi-centre, cross-sectional study, patients were classified according to Global 
Initiative for Asthma criteria into levels of asthma symptom control based on a diary card registra-
tion. We defined Step 1(‘well controlled’ asthma symptoms), Step 2(‘moderately controlled’), Step 
3(‘poorly controlled’) and Step 4(‘very poorly controlled’). These control steps were related with the 
sum score of the ACQ.
Results. from 108 asthma patients complete data were obtained. The Step 1 subgroup comprised 
17 patients; Step 2, 12 patients; Step 3, 22 patients; and Step 4, 57 patients. Receiver Operating 
Characteristic curve analysis showed that the optimal ACQ sum score cut-off value to differentiate 
between Step 1 and Steps 2, 3 and 4 was three points (sensitivity: 84%, specificity: 76%). for Steps 1 
and 2 versus Steps 3 and 4, this was four points (sensitivity: 77%, specificity: 59%).  for Steps 1,2 and 
3 versus Step 4, this was six points (sensitivity: 70%, specificity: 74%).
Conclusion. Our results show that discrimination between asthma patients with controlled and 
uncontrolled asthma symptoms, based on the ACQ, is possible with a reasonable margin of test inac-
curacy. Thus, the ACQ may be an important tool for health care professionals who aim to optimize 
the level of asthma control in their patient population.
 Lotte van den Nieuwenhof, Tjard Schermer, Petra eysink, eric Halet, Chris van Weel, 
Patrick Bindels, Ben Bottema. Fam Prac 2006; 23: 674-681
#
5
6  Asthma in general practice         
Asthma in general practice  
that has been validated and has been 
used to measure the effects of asthma 
treatment in clinical studies.13 patients 
recall their experiences during the pre-
vious week and respond to each ques-
tion on a 7-point scale, which ranges 
from 0 (well controlled) to 6 (extremely 
poor controlled). Because of the use 
of the postal mailing procedure, we 
used a shortened version of the aCQ 
in which the final question about pul-
monary function is omitted. omission 
of this question does not influence the 
validity of the aCQ.14,15 the sum of the 
six remaining items was used to cal-
culate a total aCQ-score, which could 
range from 0-36. participants were 
instructed to complete the question-
naire on the last day of their diary reg-
istration period. participants returned 
their diary cards and questionnaires 
to the department of family practice 
of the radboud university nijmegen 
medical Centre in a prepaid envelope.
Classification of asthma 
symptom control
we used the data obtained from the 
diary cards to classify patients into 
levels of asthma symptom control. in 
order to describe asthma symptom 
control we applied the asthma severity 
classification in the gina guideline 3 
to classify (the frequency of) bronchial 
symptoms and use of rescue broncho-
dilator use. patients were classified 
into one of four steps (table 1) ac-
cording to their frequency of (i) day-
time asthma symptoms; (ii) nocturnal 
asthma symptoms; (iii) limitations of 
physical activities due to asthma; and 
(iv) daily use of short-acting β2 ago-
nists. patients were classified into Step 
1 (‘well controlled’ asthma symptoms), 
Step 2 (‘moderately controlled’), Step 3 
(‘poorly controlled’) and Step 4 (‘very 
poorly controlled’). Because we used a 
postal mailing procedure for data col-
lection, the lung function criteria that 
are included in the gina classification 
(level of fev1 and pef) were not used 
in this classification. the process of 
categorizing patients into the consecu-
tive gina steps was started by looking 
at each of the four criteria separately. 
during this initial phase of the analysis 
it turned out that 85 patients (79%) re-
ported frequencies for daytime symp-
toms, nocturnal symptoms, limitation 
of daily activities and short-acting β2 
agonist use that were not all consis-
tent with one particular step. only 23 
patients (21%) in the study population 
complied with all four criteria accord-
ing to one and the same step. follow-
ing the gina guideline, the patient 
then was assigned to the highest level 
of severity of any one criterion. this 
was defined as the ‘stringent classi-
fication’. this stringent classification 
means, for instance, that a patient who 
complies with three criteria according 
to Step 1 and only one criterion accord-
ing to Step 4 is categorized in the same 
step as is a patient who complies with 
all four criteria of Step 4. therefore, we 
also formulated a less stringent clas-
sification, the ‘lenient classification’. 
in order to be categorized in Step 1, 
patients had to comply with all four cri-
teria that appertain to Step 1. for Step 
2, patients had to comply with Step 1 
or Step 2 for three criteria, but were al-
lowed to have one criterion in a higher 
step (either Step 3 or 4). for Step 3, 
patients had to comply with at least 
three of the criteria that appertain to 
Step 3 but did not have more than one 
criterion in Step 4. Step 4 subjects had 
to comply with all four criteria accord-
ing to Step 4. 
statistical analyses
data analysis was performed with 
this purpose. in particular we wanted 
to investigate if an aCQ score cut-off 
value could be established in order to 
differentiate between patients with 
adequate and inadequate asthma 
symptom control.
MeThods
design, subject recruit-
ment and measurements
this pilot study was a multi-centre, 
cross-sectional study relating individu-
als’ aCQ scores to their gina symptom 
level.3 the study aimed to analyse data 
of 100 patients with different levels 
of asthma control. in order to recruit 
these patients, 333 asthma patients 
from 8 family practices were contacted, 
of whom 88 were willing to participate. 
an additional 25 asthma patients were 
recruited through a newspaper adver-
tisement. patients had to be aged be-
tween 18 and 45 years. a diagnosis of 
chronic obstructive pulmonary disease 
(Copd) and inability to communicate 
in the dutch language were grounds 
for exclusion. the medical ethics re-
view board of the radboud university 
nijmegen medical Centre approved of 
the study.
patients were sent a diary card and 
a questionnaire in which the aCQ and 
questions on smoking habits were in-
tegrated. in order to describe the aver-
age level of asthma symptom control 
of a patient, the diary card comprised 
a 4-week registration period. the di-
ary card contained questions on the 
presence of daytime and nocturnal re-
spiratory symptoms, impact of asthma 
symptoms on daily activities and use of 
asthma medication. participants were 
instructed to fill in the diary card every 
day throughout the 4-week registra-
tion period.
the aCQ is a 7-item questionnaire 
GINA Step
sTep 1
sTep 2
sTep 3
sTep 4
• daytime symptoms* on 0-1 days/week
• nocturnal symptoms† on 0-3 nights/month
• no limitations of physical daily activities
• no daily use of inhaled short acting bronchodilators
• daytime symptoms on 2-6 days/week
• nocturnal symptoms 3-4 on nights/month
• no limitations of physical daily activities
• no daily use of inhaled short acting bronchodilators
• daytime symptoms on 7 days/week
• nocturnal symptoms on >4 nights/month
• no limitations of physical daily activities
• daily use of inhaled short acting bronchodilators
• daytime symptoms on 7 days/week
• nocturnal symptoms on >4 nights/month
• Limitations of physical daily activities
• daily use of inhaled short acting bronchodilators
*   dAyTIME SyMPTOMS: 
OnE OR MORE Of THE 
fOllOWInG SyMPTOMS: 
WHEEzInG, COuGHInG, 
SHORTnESS Of BREATH, 
TIGHTnESS CHEST duR-
InG THE dAy
†   nOCTuRnAl SyMP-
TOMS: OnE OR MORE 
Of THE fOllOWInG 
SyMPTOMS: WHEEzInG, 
COuGHInG, SHORTnESS 
Of BREATH, TIGHTnESS 
CHEST, WAkInG duRInG 
THE nIGHT And EARly 
MORnInG.
Table 1 Criteria for asthma symptom severity according to the gInA guideline3
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n (%)
age, years (sD)
geNdeR, % (n) female 
SMokeRS, % (n) current
InHAleD steroID 
uSe, % (n)# no 
Low dose
Moderate dose
High dose
BronCHoDIlAtors, 
% (n) no bronchodilator
Short-acting only
Long-acting only
Short + long-acting
aCQ SuM SCoRe  
(95% CI)
* ACQ SCORES WERE MISSInG fOR TWO PATIEnTS / # BASEd On THE GInA ClASSIfICATIOn 3 / CI: COnfIdEnCE InTERvAl
Table 2  stringent classification of asthma symptom control #
Step-1
Well 
controlled
Step-2
Moderately 
controlled
Step-3
Poorly 
controlled
Step-4
Very poorly 
controlled
17 (15.7) 12 (11.1) 22 (20.4)
35.4 (7.3) 32.6 (7.5) 36.2 (7.1)
58.8 (10) 33.3 (4) 68.2 (15)
0 (0) 16.7 (2) 25.0 (5)
58.8 (10)
11.8 (2)
23.5 (4)
5.9 (1)
25.0 (3)
50.0 (6)
16.7 (2)
8.3 (1)
45.5 (10)
27.3 (6)
13.6 (3)
13.6 (3)
1.6 (0.7-2.4) 4.6 (3.5-5.7) 5.1 (3.3-6.9)
23.5 (4)
64.7 (11)
11.8 (2)
0 (0)
0 (0)
83.3 (10)
0 (0)
16.7 (2)
31.8 (7)
45.5 (10)
13.6 (13)
9.1 (2)
57 (52.8)
34.8 (7.8)
73.7 (42)
14.5 (8)
33.9 (19)
25.0 (14)
21.4 (12)
19.6 (11)
9.6 (7.8-11.4)
3.5 (2)
64.9 (37)
8.8 (5)
22.8 (13)
Total
108 (100)
34.9 (7.5)
65.7 (71)
14.4 (15)
39.3 (42)
26.2 (28)
19.6 (21)
15.0 (16)
6.8 (5.7-8.0)
12.0 (13)
63.0 (68)
9.3 (10)
15.7 (17)
P value
0.62
0.06
0.19
0.35
<0.0001
0.007
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patients. the mean age was 34.9 years 
(Sd: 7.5), and 71 patients (65.7%) were 
females. in table 2 the characteristics 
of the participating asthma patients 
are given for the stringent classifica-
tion of asthma symptom control. 
Classification of  
asthma control
according to the stringent classifica-
tion, there were 17 patients (15.7%) 
with  ‘well controlled asthma symp-
toms’ (Step 1), 12 patients (11.1%) with 
‘moderately controlled asthma symp-
toms’ (Step 2), 22 patients (20.4%) with 
‘poorly controlled asthma symptoms’ 
(Step 3) and 57 patients (52.8%) with 
‘very poorly controlled asthma symp-
toms’ (Step 4) (table 2). using the le-
nient classification fewer patients were 
categorized as having poor asthma 
control: 17 patients (15.7%) were cat-
egorized in Step 1, 38 patients (35.2%) 
in Step 2, 47 patients (42.5%) in Step 3 
and 6 patients (5.6%) in Step 4. 
ACQ scores
for the total study population, 
the mean aCQ score was 6.8 points 
(95%Ci: 5.7; 8.0). the aCQ scores of 
the stringent classification are shown 
in table 2. as compared with the strin-
gent classification, the Step 1 patients 
of the lenient classification had an 
identical mean aCQ score (1.6 points, 
95%Ci: 0.7; 2.4),  Step 2 patients had 
a slightly lower aCQ score (4.1 points, 
95%Ci: 3.2; 5.0), whereas Steps 3 and 
4 patients showed substantially higher 
aCQ scores (9.8 points, 95%Ci: 8.1; 
11.6, and 16.7 points, 95%Ci: 9.0; 24.3, 
respectively). again, one-way anova 
testing showed that the differences 
in aCQ scores between the four steps 
were statistically significant (p < 0.001). 
the scatter plots in fig. 1 show a con-
siderable overlap in the aCQ scores 
of the patients in Steps 1 to 4 for the 
stringent as well as for the lenient clas-
sification.
optimal cut-off 
for ACQ values  
figure 2 shows - for the stringent clas-
sification - the roC curves for the aCQ 
cut-off values to distinguish asthma 
1 2 3 4
Asthma Symptom Control Steps, Stringent classification
0
10
20
30
Su
m
sc
or
e 
of
 A
C
Q
Figure 1. a Scatterplot of aCQ sum-
score versus asthma symptom control 
steps, stringent classification.
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Asthma Symptom Control Steps, Lenient classification
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Figure 2. B Scatter plot of aCQ sum 
score versus asthma symptom control 
steps, lenient classification.
SpSS 12.0 for windows. a series of re-
ceiver operating Characteristic (roC) 
curves were created to determine the 
optimal aCQ cut-off values to distin-
guish (i) Step 1 patients from Steps 2, 
3 and 4 patients; (ii) Steps 1 and 2 pa-
tients from Steps 3 and 4 patients; (iii) 
Steps 1, 2 and 3 patients from Step 4 
patients for the stringent  and lenient 
classifications. a cut-off point with a 
sensitivity of 0.80 and a specificity of 
0.80 was considered the most appro-
priate cut-off value for the aCQ. for 
each roC curve the area under the 
curve (auC) and the accompanying 
95% confidence interval (95%Ci) was 
calculated. differences between the 
various steps were analysed by Chi 
square and one-way anova (analysis 
of variance) testing. 
ResuLTs
study population
a total of 113 patients with asthma 
participated in the study. of all pa-
tients, 88 (78%) had been recruited 
by the fps involved in the study and 
25 through the newspaper advertise-
ment. valid diary cards were missing 
for five patients and aCQ scores were 
missing for two patients. thus, data for 
further analysis were available for 108 
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*  THE SMAllEST CuTOff vAluE IS THE MInIMuM OBSERvEd TEST 
vAluE MInuS 1, And THE lARGEST CuTOff vAluE IS THE MAxIMuM 
OBSERvEd TEST vAluE PluS 1. All THE OTHER CuTOff vAluES ARE THE 
AvERAGES Of TWO COnSECuTIvE ORdEREd OBSERvEd TEST vAluES.
*  THE SMAllEST CuTOff vAluE IS THE MInIMuM OBSERvEd TEST 
vAluE MInuS 1, And THE lARGEST CuTOff vAluE IS THE MAxIMuM 
OBSERvEd TEST vAluE PluS 1. All THE OTHER CuTOff vAluES ARE THE 
AvERAGES Of TWO COnSECuTIvE ORdEREd OBSERvEd TEST vAluES.
*  THE SMAllEST CuTOff vAluE IS THE MInIMuM OBSERvEd TEST 
vAluE MInuS 1, And THE lARGEST CuTOff vAluE IS THE MAxIMuM 
OBSERvEd TEST vAluE PluS 1. All THE OTHER CuTOff vAluES ARE THE 
AvERAGES Of TWO COnSECuTIvE ORdEREd OBSERvEd TEST vAluES.
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may be a good and simple mailing tool 
to guide fps in detecting patients with 
poor asthma symptom control in their 
practice.
in terms of demographics or illness 
severity our study population does 
probably not fully represent the fam-
ily practice asthma population. for 
instance, women were over-repre-
sented, especially in the poorly and 
very poorly controlled subgroups. also, 
we studied patients aged between 18 
and 45 years. the upper age limit of 45 
was chosen to exclude patients with 
Copd as much as possible, although 
assessing asthma control would obvi-
ously not have to be limited to this age 
group. in our view, the lack of external 
validity is only of limited relevance. 
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Figure 3. RoC curves for the aCQ 
cutoff values to distinguish asthma 
patients in Step 1 from Step 2,  and 
4 (panel A), step 1 and 2 from step 
3 and 4 (panel B) and step 1,2 and 3 
from 4 (panel C)
patients in Step 1 from those in Steps 
2, 3 and 4 (fig. 2a), Steps 1 and 2 pa-
tients from Steps 3 and 4 patients (fig. 
2B), and Steps 1, 2 and 3 patients from 
Step 4 patients (fig. 2C) and the accom-
panying sensitivities and 1-specificities 
(tables 3, 4 and 5). table 6 shows that 
for the stringent classification an aCQ 
cut-off score of >3 points best discrimi-
nated between patients with good 
(Step 1) and patients with moderate or 
worse asthma symptom control (Steps 
2, 3, and 4). an aCQ score of >4 points 
distinguished between patients with 
good or moderate symptom control 
(Steps 1 and 2) and patients with (very) 
poor symptom control (Steps 3 and 
4), whereas an aCQ score of >6 points 
best detected patients with very poor 
symptom control. except for the dif-
ferentiation between Step 1 and Steps 
2 to 4, the aCQ cut-off values were 
higher when the lenient classification 
was used.
dIsCussIon
the aim of this pilot study was to 
explore whether it is possible for pri-
mary care physicians to differentiate 
between patients with controlled and 
uncontrolled asthma symptoms on 
the basis of the shortened version of 
the aCQ. a simple but valid method to 
make this differentiation would enable 
fps to efficiently select those asthma 
patients who are in most need of 
their attention. the results of this ex-
ploratory study indicate that the aCQ 
-1.00
0.50
1.50
2.50
3.50
4.50
5.50
6.50
7.50
8.50
9.50
10.50
11.50
12.50
13.50
15.00
16.50
17.50
21.50
32.00
ACQ 
CuToFF*
sensITIvITy 1
speCIFICITy
Table 3 Coordinates Panel a, Figure 2
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symptoms.6,7,17,18 although we did not 
investigate this in the current study, 
there is evidence that better asthma 
control improves the overall health 
status of patients.9 identification of 
patients with poorly controlled asthma 
would give practitioners the opportu-
nity to raise the level of asthma control 
and, consequently, the health status in 
their practice population.
in order to be able to compare the 
results of studies on asthma control, 
it is important to have consensus on 
a definition of bronchial symptom 
control. Cockcroft and Swystun19 have 
reported that most of the criteria de-
scribing asthma severity also describe 
the lack of asthma control, but that 
asthma control and asthma severity 
are two different concepts. however, 
in the absence of an instrument to ac-
tually measure asthma control we used 
the criteria for disease severity of the 
widely accepted gina guideline.3 the 
four steps of asthma symptom control 
we applied have previously been used 
by other investigators.5,6,17 we found 
the gina criteria for asthma symp-
toms not to be mutually exclusive: 
a significant part (79%) of our study 
population could be allocated to more 
than one step at the same time. fol-
lowing the gina guideline the patient 
then has to be assigned to the highest 
level of severity of any one criterion 
(the ‘stringent’ classification) meaning 
that a patient who has, for instance, 
three criteria indicating good asthma 
symptom control and just one crite-
rion indicating poor control is ‘forced’ 
into the same category as a patient 
who has poor control according to all 
four criteria. this means that a larger 
proportion of patients will be catego-
rized as having poor asthma symptom 
control. in the stringent classification, 
indeed a great part of patients(53%) 
are very poorly controlled (Step 4). in 
our lenient classification there was 
only a small number (6%) of patients 
with poorly controlled asthma symp-
toms (Step 4), which probably would 
be more compatible with a study in 
the primary care setting, as the dutch 
asthma guideline advises patients with 
very poor asthma symptom control to 
be referred for further care by a respi-
ratory physician.4 as a comparison, the 
asthma insights and reality in europe 
(aire) Study reported a proportion of 
15 to 28% of all patients with asthma 
to suffer from uncontrolled asthma 
across seven countries in western eu-
rope.20
when using the more stringent 
classification we found lower cut-off 
values for the aCQ score to discrimi-
nate between asthma patients with 
decreasing levels of symptom control 
than with the lenient classification. 
STeP 1 veRSuS  
STeP 2,  aNd 
STeP1 aNd 2  
veRSuS STeP  aNd 
STeP 1, 2 aNd   
veRSuS STeP 
Lenient classification
STeP 1 
veRSuS STeP 2, , aNd 
STeP 1 aNd 2  
veRSuS STeP  aNd 
STeP 1, 2, aNd  
veRSuS STeP 
Table 6 ACQ cutoff values and test characteristics to discriminate between subgroups 
of asthma symptom control
Contrast Optimal cutoff  
for ACQ sum score
AUC 
(95%CI)
Sensitivity Specificity
3 0.88 
(0.81-0.95)
0.84 0.76
4 0.80 
(0.71; 0.88)
0.77 0.59
3 0.88 
(0.81; 0.945)
0.84 0.76
6 0.88 
(0.81; 0.94)
0.80 0.80
9 0.90 
(0.82; 0.98)
1.00 0.76
Stringent classification
6 0.79 
(0.70-0.87)
0.70 0.74
2  Asthma in general practice         
Asthma in general practice  
most important in this exploratory 
study was to include patients with dif-
ferent levels of asthma control in order 
to see whether the aCQ could discrimi-
nate between these different levels of 
asthma symptom control. however, 
a similar study in a larger cohort of 
asthma patients with a wider age range 
and a wide spectrum of levels of symp-
tom control is needed to confirm our 
findings. from such research it could 
also become clear how relevant it is 
to check on medication non-compli-
ance (which is a very common feature 
in patients with asthma)16once a pa-
tient is identified as having suboptimal 
control. further research in this field is 
certainly needed, as up until now we 
have not been able to trace other stud-
ies in which the actual identification of 
patients with poor asthma control in 
a primary care setting with the aid of 
simple methods has been investigated. 
future studies should also take into ac-
count that improved asthma control 
might come at the price of adverse 
effects of the medication (i.e. inhaled 
corticosteroids) that is needed to 
achieve a higher level of control.
an objective way to screen for asthma 
symptom control is important because 
there is a discrepancy between asthma 
patients’ self-reported level of control 
and the level of control that is mea-
sured objectively. asthma patients 
tend to underestimate their asthma 
*  THE SMAllEST CuTOff vAluE IS THE MInIMuM OBSERvEd TEST vAluE MInuS 1, And THE lARGEST CuTOff vAluE IS THE MAxIMuM OBSERvEd 
TEST vAluE PluS 1. All THE OTHER CuTOff vAluES ARE THE AvERAGES Of TWO COnSECuTIvE ORdEREd OBSERvEd TEST vAluES.
ACQ: ASTHMA COnTROl QuESTIOnnAIRE / AuC: AREA undER THE CuRvE / CI: COnfIdEnCE InTERvAl
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our stringent analysis showed that a 
cut-off value for the aCQ score of >3 
points best discriminated patients with 
good asthma symptom control from 
patients with moderate or worse con-
trol. an aCQ score of >4 was the most 
suitable cut-off to select patients with 
(very) poor symptom control. and an 
aCQ score of >6 points was the most 
suitable cut-off to select patients with 
very poor symptom control. although, 
as explained above, we need to be 
careful with the interpretation of these 
values because the study participants 
may not represent normal asthma 
population. the cut-off value for the 
aCQ score used is dependent upon 
what a fp wishes to achieve as well as 
on the time and manpower available. 
if the goal is to detect only the patients 
with poorly controlled asthma symp-
toms, the cut-off value of >6 points 
on the aCQ seems to be the most ap-
propriate choice. if the fp wants to see 
all asthma patients with suboptimally 
controlled symptoms, a lower cut-off 
value on the aCQ (>3) should be con-
sidered. also, when using our cut-off 
values for individual patients it should 
be kept in mind that there was an over-
lap of aCQ scores between the step 
categories, with the exception of Step 
1 and Step 4 patients in the lenient cat-
egorization. 
instead of using the mean aCQ score, 
which is commonly used, we used the 
sum score of the aCQ items, because 
calculation of the mean score compli-
cates the application of the instrument 
in daily clinical practice. as long as 
there are no missing values among the 
six items - in our population this was 
the case for only 3.5 % of patients – the 
interpretation is the same. the aCQ 
questionnaire had to be completed on 
the final day of the 4-week diary card 
observation period. although diaries 
and questionnaires are commonly used 
research tools, there are shortcomings 
of this method. it has been reported 
that not all patients are perfectly com-
pliant with completing questionnaires 
and diary cards.21 however, it seems 
unlikely that there has been a relevant 
dependency between the diary card 
recordings and the aCQ score: the aCQ 
items were part of a larger question-
naire that the participants completed 
on the final observation day; it seems 
unlikely that patients would take the 
trouble to trace the actual aCQ ques-
tions in the questionnaire and directly 
compare their responses with the pre-
viously recorded diary card entries.
in conclusion, the aCQ seems to be 
a helpful screening tool to distinguish 
asthma patients with good symptom 
control from patients with poor symp-
tom control in an objective and feasible 
way. we found that it was possible to 
define a cut-off value for the aCQ score 
for this purpose. however, which cut-
off value is most appropriate depends 
on the goals a health care professional 
has. when resources are limited, the 
goal might be to detect only patients 
with poorly controlled asthma symp-
toms, and an aCQ cut-off of >6 points 
would seem appropriate. if there are 
no restraints in time or manpower a 
more ambitious goal can be set, for in-
stance, not to miss any asthma patients 
with a suboptimal level of symptom 
control. in that case an aCQ cut-off of 
>3 points seems apposite. this way of 
applying the aCQ may provide health 
care professionals with a good and ef-
fective starting point to actively detect 
patients with uncontrolled asthma 
symptoms in their practice, and to pro-
vide them with an important tool to 
optimize the level of asthma symptom 
control in their patient population.
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Tracing Uncontrolled Asthma 
in Family Practice Using a Mailed 
Asthma Control Questionnaire
ABSTRACT
PURPOSE A substantial proportion of adult patients with asthma have inad-
equately controlled symptoms despite the availability of effective treatment. The 
Asthma Control Questionnaire (ACQ) can be used to discriminate between asthma 
patients with well- and suboptimally controlled asthma symptoms. The objective 
of this study was to investigate whether a postal mailing of the ACQ can be used 
to identify asthma patients with suboptimal symptom control in family practice. 
METHODS In this observational study, we sent 434 asthma patients from 6 Dutch 
family practices an ACQ by mail to measure control of their asthma symptoms. 
Both respondents and nonrespondents were characterized by information gathered 
from their medical records. Patients with an ACQ sum score (total score) of greater 
than 3 were considered to have suboptimally controlled asthma symptoms.
RESULTS The response rate was 77%. Respondents were more likely than non-
respondents to be female and to use asthma medication. The mean ACQ sum 
score of the respondents was 5.2. Of this group, 53.4% (95% confi dence inter-
val, 48.0%-58.8%) had suboptimally controlled asthma symptoms. Of the 168 
respondents who had not visited their family physician in the 2 years before the 
study, 42.9% (95% confi dence interval, 35.4%-50.4%) had inadequate asthma 
symptom control.
CONCLUSIONS Our results show that a postal mailing of the ACQ is an effective 
approach for tracing asthma patients who need medical attention. It also traces 
patients who would otherwise not have consulted their family physician. The ACQ 
seems to be a useful starting point for health care professionals in family practice 
to improve the level of asthma symptom control in their patient population.
Ann Fam Med 2008;6(suppl 1):s16-s22. DOI: 10.1370/afm.776.
INTRODUCTION
Population surveys have shown that despite the availability of highly effective pharmacotherapy, the majority (up to 70%-95%) of all asthma patients in western Europe and the Asia-Paciﬁ c region have 
signs of poor asthma control.1-3 Known causes of this suboptimal level 
of asthma control are poor adherence to periodic management visits to 
health care professionals4-6 or insufﬁ cient compliance with prescribed 
asthma medication, especially inhaled corticosteroids.5 In addition, 
patients with asthma—and their physicians—tend to overestimate their 
level of asthma control.7,8 These factors emphasize the need to improve 
the identiﬁ cation of poor asthma control and subsequent treatment. 
Because the majority of patients with asthma are treated by family physi-
cians, family practice would be the most appropriate setting to study the 
tracing of patients with poor asthma control. 
Bronchial inﬂ ammation is a marker of asthma control that can be 
assessed by induced sputum eosinophilia9 or bronchial hyperrespon-
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siveness.10 The requirement of laboratory facilities, 
the time-consuming nature of these tests, and their 
unfriendliness to patients severely hamper their routine 
use in primary care, however. An increase of asthma 
symptoms has been shown to indicate a loss of asthma 
control,11,12 making measurement of changes in symp-
toms an attractive alternative to the above tests.
In a previous study,13 we found that the Asthma Con-
trol Questionnaire (ACQ)14-16 can be used to distinguish 
asthma patients with good symptom control from those 
with suboptimal symptom control. The aim of the cur-
rent study was to investigate whether a mailing of the 
ACQ can be used to trace asthma patients with subopti-
mal symptom control in the family practice population.
METHODS
Design and Patient Recruitment
This was a multicenter observational study conducted 
in 6 family practices from the Amsterdam (n = 3) and 
Nijmegen (n = 3) regions in the Netherlands. In the 
Netherlands, patients are registered with a family phy-
sician, who largely coordinates access to health care 
services. The study was approved by the medical eth-
ics review board of the Radboud University Nijmegen 
Medical Centre. 
We selected patients with asthma from the practices’ 
computerized medical records using 2 inclusion criteria: 
(1) an age of 18 to 45 years and (2) a diagnostic label of 
asthma and/or, during the 2 years preceding the study, 
at least 1 prescription for an inhaled corticosteroid and/
or at least 2 prescriptions for an inhaled bronchodila-
tor. The family physicians received a list of all selected 
patients in their practice and were asked to exclude any 
who had a diagnosis of chronic obstructive pulmonary 
disease or who were unable to communicate in Dutch. 
Measures
For all patients, we extracted the following informa-
tion from their family practice medical records: (1) sex, 
(2) age, and (3) in the 2 years preceding the study, num-
ber of visits to the family physician for asthma-related 
complaints, asthma exacerbations, prescriptions for 
asthma medication (β2 agonists, anticholinergics, inhaled 
and oral corticosteroids, cromoglycates, leukotriene 
antagonists), referrals to chest physicians, asthma-related 
emergency department visits, and hospital admissions.
In an initial mailing, patients were sent the ACQ 
from their family physician with a cover letter and a 
prepaid return envelope. In a reminder mailing, sent to 
patients who had not responded 4 weeks after the initial 
mailing, patients received a reminder letter along with 
another ACQ and another prepaid return envelope.
The ACQ14 contains a set of questions that allow 
patients with asthma to rate the severity of their respi-
ratory symptoms (Table 1). Patients are asked to recall 
their respiratory health status during the previous week 
and respond to each question on a 7-point scale rang-
ing from 0 (well controlled) to 6 (extremely poorly 
controlled). The ACQ has been validated and has been 
Table 1. Asthma Control Questionnaire16-18
1.  On average, dur-
ing the past week, 
how often were you 
woken by your 
asthma during the 
night?
0 Never
1 Hardly ever
2 A few times
3 Several times
4 Many times
5 A great many times
6  Unable to sleep because 
of asthma
4.  In general, during the past 
week, how much short-
ness of breath did you 
experience because of 
your asthma?
0 None
1 A very little
2 A little
3 A moderate amount
4 Quite a lot
5 A great deal
6 A very great deal
2.  On average, during 
the past week, how 
bad were your 
asthma symptoms 
when you woke 
up in the morning?
0 No symptoms
1 Very mild symptoms
2 Mild symptoms
3 Moderate symptoms
4 Quite severe symptoms
5 Severe symptoms
6 Very severe symptoms
5.  In general, during the past 
week, how much of the 
time did you wheeze?
0 Never
1 Hardly any of the time
2 A little of the time
3 A moderate amount of the time
4 A lot of the time
5 Most of the time
6 All the time
3.  In general, during 
the past week, how 
limited were you 
in your activities 
because of your 
asthma?
0 Not limited at all
1 Very slightly limited
2 Slightly limited
3 Moderately limited
4 Very limited
5 Extremely limited
6 Totally limited
6.  On average, during the 
past week, how many 
puffs/inhalations of 
short-acting bronchodila-
tor (eg, Ventolin, Bricanyl) 
have you used each day?
(If you are not sure how to 
answer this question, please 
ask for help.)
0 None
1 1-2 puffs/inhalations most days
2 3-4 puffs/inhalations most days
3 5-8 puffs/inhalations most days
4 9-12 puffs/inhalations most days
5 13-16 puffs/inhalations most days
6 More than 16 puffs/inhalations most days
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used to measure the effects of asthma treatment in 
clinical studies.14-17 Initially, the questionnaire included 
a question on pulmonary function, but omission of that 
question did not inﬂ uence the validity of the ACQ.16,18 
The questionnaire was therefore modiﬁ ed to the 6-
question ACQ used in this study.16-18 
Analysis
We used the sum score (total score) of the ACQ’s 6 
questions (range, 0-36 points)—instead of the mean 
score, which is generally used—because this is easier to 
calculate in daily practice. As long as patients answer 
all questions, the interpretation is the same. The higher 
the sum score, the poorer patients’ asthma control.
In a previously reported pilot study,13 we estab-
lished an ACQ cutoff value for identifying patients 
with asthma who have suboptimal control of their 
symptoms. A sum score of 3 points or less best indi-
cated good asthma symptom control, having a sensitiv-
ity of 84% and a speciﬁ city of 76%. 
A primary respondent was deﬁ ned as a patient who 
returned the ACQ after the ﬁ rst mailing, and a second-
ary respondent was deﬁ ned as a patient who returned the 
ACQ after the reminder mailing. Nonrespondents 
were patients who did not return the ques-
tionnaire after these 2 consecutive attempts. 
Patients who had visited their family physician 
for asthma-related complaints during the 2-year 
period before the mailing were deﬁ ned as visi-
tors, and those who had not were deﬁ ned as 
nonvisitors. 
We performed data analysis with SPSS 
version 12.0 for Microsoft Windows (SPSS 
Inc, Chicago, Illinois). Various study groups 
were compared with regard to the informa-
tion extracted from their medical records 
and—apart from the nonrespondents—their 
ACQ sum scores. Speciﬁ cally, we compared 
differences between respondents overall and 
nonrespondents, between primary and sec-
ondary respondents, and between visitors and 
nonvisitors using the χ2, Mann Whitney U, 
and 1-way ANOVA statistical tests. A 95% 
conﬁ dence interval (CI) was calculated for the 
most relevant proportions.
RESULTS
Mailing Response and Study Population
We identiﬁ ed and sent the ACQ to 434 
patients with asthma from the 6 family prac-
tices who met the inclusion and exclusion 
criteria. Patient ﬂ ow in the study is shown 
in Figure 1. A total of 333 patients or 76.7% 
(95% CI, 72.7%-80.7%) of all patients who were sent 
the ACQ returned it. 
Characteristics of the respondents overall and non-
respondents are shown in Table 2. Compared with non-
respondents, respondents were more likely to be female 
(62.5% vs 45.5%), were slightly older (34.6 vs 32.6 
years), and were more likely to be using asthma medica-
tion in general (79.6% vs 61.4%) and inhaled corticoste-
roids in particular (28.8% vs 16.8%). We found no other 
statistically signiﬁ cant differences between these groups.
Characteristics of the primary respondents and sec-
ondary respondents are shown in Table 3. Compared 
with secondary respondents, primary respondents 
consulted their family physician more frequently (1.3 
vs 0.8 times in the preceding 2 years) and were more 
likely to be using any asthma medication (83.2% vs 
69.7%). These groups were otherwise statistically 
indistinguishable. 
Symptom Control in Respondents 
and Nonrespondents
In the 2 years preceding the mailing, in the nonrespon-
dent group, 1 patient had been admitted to the hospital 
Figure 1. Patient fl ow. 
ACQ = Asthma Control Questionnaire.14,16
Asthma patients registered in 
6 family practices on fi nal mailing lists
N = 434
Initial postal mailing of ACQ
Primary respondents
n = 244 (56.2%)
Complete ACQ: n = 241 (98.8%)
Total respondents
n = 333 (76.7%)
Complete ACQ: n = 326 (97.9%)
Incomplete ACQ: n = 7 (2.1%)
Total nonrespondents
n = 101 (23.3%)
Secondary respondents
n = 89 (20.5%)
Complete ACQ: n = 85 (95.5%)
Incomplete ACQ: n = 4 (4.5%)
Initial nonrespondents
n = 190 (43.8%)
Reminder mailing of ACQ
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and 1 patient had visited an emergency department 
because of an acute asthma attack. None of the patients 
in the respondent group had experienced either of 
these events. 
The mean ACQ sum score of the respondents was 
5.2 points (Table 2). Secondary respondents had a 
lower ACQ sum score than primary respondents (4.8 
vs 5.3 points), although the difference was not sig-
niﬁ cant (Table 3). The distribution of the ACQ sum 
scores among all respondents is depicted in Figure 
2. When primary and secondary respondents with a 
complete ACQ were combined (n = 326), fully 53.4% 
(95% CI, 48.0%-58.8%) of respondents had symptoms 
of suboptimally controlled asthma (ie, an ACQ sum 
score >3 points). 
Symptom Control in Visitors and Nonvisitors
A total of 207 of the patients who received the mailed 
ACQ from their family physician, or 47.7% (95% CI, 
43.0%-52.4%), met the deﬁ nition of visitors because 
they had at least 1 documented asthma-related family 
physician visit during the preceding 2 years. Of the 
174 respondents with suboptimally controlled symp-
toms, 58.6% had at least 1 visit. According to their 
medical records, visitors had had an average of 2.4 
(SD, 2.0) asthma-related consultations. 
Patients completing the ACQ were nearly equally 
split by visitation status: 158 (48.4%) were visitors and 
168 (51.6%) were nonvisitors. Compared with the visi-
tors, the nonvisitors had better asthma symptom control: 
the mean ACQ sum score was 3.9 points (SD, 4.5) for 
nonvisitors and 6.5 points (SD, 5.6) for visitors (P <.001). 
Still, 42.9% (95% CI, 35.4%-50.4%) of the 168 nonvisi-
tors who returned their ACQ had suboptimal symptom 
control (ie, an ACQ sum score >3 points), although this 
was less than the 64.6% value among visitors.
DISCUSSION 
A main goal in the management of asthma is to 
achieve optimal control of respiratory symptoms,20 but 
recent surveys show that there is considerable room 
for improvement with regard to the level of asthma 
control in the general population.1-3 As best we could 
determine, no other studies have attempted to identify 
patients with poor asthma symptom control in a pri-
mary care setting with the aid of a simple method. The 
main objective of our study, therefore, was to evalu-
ate whether a mailing of the 
ACQ can be used to identify 
patients with suboptimal 
symptom control among all 
patients registered in a family 
practice who have asthma. 
With the ACQ mailing, 
we were able to reach 77% 
of all the asthma patients 
registered in the participating 
family practices, including a 
rather large group of patients 
who had not had a single con-
tact for respiratory complaints 
with their family physician in 
the past 2 years. When using 
our previously determined 
cutoff value of an ACQ sum 
score of greater than 3, we 
found that about 1 out of 
every 2 asthma patients (53%) 
in these family practices were 
classiﬁ ed as having subop-
timally controlled asthma 
symptoms. A somewhat 
higher prevalence of subopti-
mal asthma control (60%) has 
been reported earlier.21 
Other researchers have 
found that the cutoff value 
Table 2. Characteristics of All Patients Sent the ACQ and of Respondents 
and Nonrespondents
Characteristic
Total
(N = 434)
Group
P Value
Nonrespondents
(n = 101)
Respondents*
(n = 333)
Female 58.5 (254) 45.5 (46) 62.5 (208) .003†
Age, mean (SD), years 34.1 (7.5) 32.6 (7.5) 34.6 (7.5) .02‡
Visitors§ 47.7 (207) 47.5 (48) 47.7 (159) .97†
Consultations,ll mean (SD), No. 1.1 (1.8) 1.0 (1.6) 1.2 (1.9) .45¶
Use of any asthma medication# 75.3 (327) 61.4 (62) 79.6 (265) <.001†
Use of inhaled steroid 26.0 (113) 16.8 (17) 28.8 (96) .02†
Low dose** 8.5 (37) 17.6 (3) 35.8 (34) –
Intermediate dose** 9.4 (41) 29.5 (5) 37.9 (36) .08†
High dose** 7.8 (34) 52.9 (9) 26.4 (25) –
Short-acting bronchodilator 23.7 (103) 19.8 (20) 24.9 (83) .29†
Long-acting β2 agonist 6.0 (26) 5.0 (5) 6.3 (21) .61†
Asthma exacerbation†† 12.0 (52) 8.9 (9) 12.9 (43) .28†
ACQ sum score, mean (SD) – – 5.2 (5.2) –
ACQ = Asthma Control Questionnaire.14,16
Note: Values are % (No.) unless indicated otherwise.
* Primary and secondary respondents combined.
† Calculated with the χ2 test.
‡ Calculated with the 1-way analysis of variance test.
§ Patients who visited their family physician for respiratory complaints, including visits for asthma exacerbations.
ll In the 2 years preceding the ACQ mailing.
¶ Calculated with the Mann-Whitney U test.
# Receipt of at least 1 prescription for a bronchodilator or an inhaled steroid in the 2 years preceding the ACQ 
mailing.
** Proportion of inhaled steroid users; dosing groups are based on the Global Initiative for Asthma (GINA) 
classifi cation.19
†† At least 1 exacerbation for which prednisolone or antibiotics were prescribed. 
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of 3 has as sensitivity of 90% and a speciﬁ city of 
58%17; however, the ACQ cutoff value that is most 
appropriate depends on the health care professional’s 
goals. When resources are limited, the goal might be 
to identify only patients with very poorly controlled 
asthma symptoms, and a higher ACQ cutoff might be 
more appropriate.13 
An interesting observation was that a substantial 
proportion of the visitors (65%) still had suboptimal 
symptom control. In fact, this proportion was even 
greater than that among the nonvisitors (43%). From 
these ﬁ ndings, we conclude that the largest number 
of patients with suboptimal control of their asthma 
was found among those who had visited their fam-
ily physician recently for asthma. This association 
indicates that regular consultation of the family physi-
cian does not always indicate well-controlled asthma. 
It has previously been shown that patients as well as 
their physicians do not always adequately recognize 
suboptimal asthma control,7,8 which possibly explains 
part of this pattern. On the other hand, 
because asthma is usually treated as an 
episodic disorder, asthma patients who 
visit their family physician probably have 
more asthma-related problems. This study 
provides empiric data that this is the case, 
but also that the situation is more complex 
than that, given that poor control was also 
common among nonvisitors. 
 Although mailing visitors an ACQ is a 
feasible way to identify suboptimal asthma 
control, as this study has demonstrated, we 
question the relevance of this approach for 
this group. Identiﬁ cation of poorly con-
trolled symptoms is only the initial step, 
and it should lead to better management. 
For these visitors, a more efﬁ cient approach 
would in all probability be to include the 
ACQ in their regular follow-up visits. Judg-
ing from our ﬁ ndings, that approach would 
identify the largest number of patients with 
poorly controlled asthma in the family 
practice population.
Mailing the ACQ does 
make sense for the population 
of patients who have asthma 
but do not make regular asthma 
visits to their family physician. 
Our ﬁ ndings conﬁ rm that this is 
a substantial proportion of the 
asthma population. An interest-
ing area for further study would 
be the follow-up on this ﬁ nding. 
A logical next step for the non-
visitors would be to invite those 
with high ACQ sum scores (eg, 
>3 points) to visit their family 
physician or practice nurse. This 
visit could be used to identify 
yet unidentiﬁ ed triggers for the 
poor asthma symptom control, 
discuss the patients’ personal 
preferences, and evaluate their 
current asthma management, 
Table 3. Characteristics of Primary Respondents 
and Secondary Respondents
Characteristic
Primary 
Respondents
(n = 244)
Secondary 
Respondents
(n = 89) P Value
Female 65.2 (159) 55.1 (49) .09*
Age, mean (SD), years 34.6 (7.3) 34.6 (8.1) .94†
Visitors‡ 50.4 (123) 40.4 (36) .11*
Consultations,§ mean (SD), No. 1.3 (2.1) 0.8 (1.2) .03ll 
Use of any asthma medication¶ 83.2 (203) 69.7 (62) .007*
Asthma exacerbation# 13.9 (34) 10.1 (9) .46*
ACQ sum score, mean (SD) 5.3 (5.3) 4.8 (5.2) .49ll
ACQ = Asthma Control Questionnaire.14,16
Note: Values are % (No.) unless indicated otherwise.
* Calculated with χ2 test.
† Calculated with 1-way analysis of variance test.
‡ Patients who visited their family physician for respiratory complaints, including visits for 
asthma exacerbations.
§ In the 2 years preceding ACQ mailing. Calculated with Mann-Whitney U test.
¶ At least 1 prescription for a bronchodilator or an inhaled steroid in the 2 years preceding the 
ACQ mailing.
# At least 1 exacerbation for which prednisolone or antibiotics were prescribed.
Figure 2. Distribution of ACQ sum scores among all respondents 
with a complete ACQ (n = 326). 
ACQ = Asthma Control Questionnaire.14,16
Note: Dashed line indicates ACQ cutoff value for asthma patients with suboptimal asthma symptom control 
(>3 points).13
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which is likely to offer substantial room for improve-
ment.22,23 As 57% of the nonvisitors have well-con-
trolled symptoms and do not need an extra visit, the 
ACQ can therefore be used to efﬁ ciently identify 
which nonvisitors need extra attention. We expect, 
however, that fewer patients with suboptimally con-
trolled asthma will be found among the nonvisitors 
than among the visitors. As the nonvisitors did not 
visit their family physician on their own initiative, one 
might ask whether they would respond to an invitation 
to an asthma review; however, their completion of the 
ACQ might indicate that they are not unwilling but 
only unaware of their poor asthma control. This would 
be an interesting area for further study.
In this study, we evaluated a postal mailing with 
a single reminder mailing after 4 weeks in the case of 
initial nonresponse. We considered this approach to 
be feasible for any family practice. More than one-
half of all approached patients responded to the initial 
questionnaire mailing, and the response rate further 
increased to three-quarters of all approached patients 
after a reminder was sent. 
Secondary respondents did not have more asthma 
problems than primary respondents. One might have 
expected that patients who were reluctant to respond 
to a health questionnaire would also be reluctant to 
follow treatment. But judging from the rates of poor 
asthma control, there are no indications that second-
ary respondents fared worse in their asthma (self-) 
management. It would be interesting to know how 
this ﬁ nding relates to that among patients who did not 
respond at all to the ACQ. Although we regard our 
response rate to be satisfactory, no information on the 
current level of symptom control could be gathered in 
1 of every 4 asthma patients. Relative to respondents, 
nonrespondents were more likely to be male and were 
less likely to use inhaled corticosteroids. Other inves-
tigators have also reported that men are less likely 
than women to respond to postal mailings.24,25 It has 
been suggested that when using symptom-orientated 
questionnaires, individuals with health problems may 
respond more often than those without.26 On the 
other hand, a report from an epidemiologic study on 
respiratory health found that nonrespondents experi-
enced more respiratory symptoms than respondents 
did.25 It is therefore possible that some of the asthma 
patients in our study who did not return questionnaires 
experienced more symptoms than their responding 
counterparts, and their lack of response may have 
concealed a poor level of asthma control among the 
nonrespondents. The information obtained from the 
medical records did not, however, point to a higher 
rate among the nonrespondents of respiratory-related 
family physician consultations, hospitalizations, or 
emergency department visits for asthma, or respiratory 
medication use.
When selecting patients with asthma for inclusion 
in this study, we could use only the information that 
was routinely recorded in the family physicians’ com-
puterized patient journal system. We could therefore 
not verify if every patient on the mailing list actually 
met the current national27 or international20 diagnostic 
criteria for asthma. Because patient records may not 
always be up to date with regard to the labels attached, 
our reliance on records may have led to some misclas-
siﬁ cation of patients selected for the mailing. 
In conclusion, we found that the majority of adult 
asthma patients registered in Dutch family practices 
responded to a postal mailing with a short question-
naire regarding asthma symptom control—in our 
case, the ACQ. This mailing reached asthma patients 
who would otherwise not have come to the atten-
tion of the family physician. In this group of patients, 
there certainly seemed to be room for improvement 
in management given the apparently high prevalence 
of suboptimal control of their asthma symptoms. Our 
ﬁ ndings suggest that a postal mailing of the ACQ may 
be an appropriate starting point for identifying patients 
in a family practice who have suboptimal control of 
asthma symptoms.
To read or post commentaries in response to this article, see it 
online at http://www.annfammed.org/cgi/content/full/6/suppl_1/s16.
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To the Editor:
in the march 2007 issue of the Journal, apter1 discusses the studies about risk factors for asthma and its course and management that were published in 2006 and are relevant to clinical practice. the article covers a wide range of 
current asthma topics in a condensed way. in the paragraph on measuring asthma 
control, apter1 notes that asthma control is an important variable in clinical stud-
ies. we fully agree with this statement but would like to add that asthma control 
is not just an important variable in clinical studies but also highly relevant for daily 
clinical practice. Seventy percent or more of all patients have poorly controlled 
asthma, and the majority of these patients do not realize this.2,3 therefore, to 
improve asthma control in our patients, an objective tool to identify and quantify 
suboptimal asthma control would be of great help.
we also agree with the author that so-called biomarkers to assess asthma con-
trol are too expensive and complex for routine clinical application. apter1 re-
fers to the asthma Control test4—a reliable self-report tool to measure asthma 
control—that has been validated for patients with asthma with mild symptoms 
treated by secondary care asthma specialists. however, this tool has not yet been 
validated for detecting poorly controlled patients among all patients with asthma. 
Because most patients with asthma are diagnosed and treated in primary care, 
especially in primary care a tool to identify poor asthma control would be very 
helpful. for this situation, the asthma Control Questionnaire,5,6 which has been 
extensively validated, may give primary care physicians a good starting point to 
detect actively patients with uncontrolled asthma symptoms in their practice7 
and improve their level of asthma symptom control. asthma control is not only an 
important clinical study outcome; detecting (and subsequently improving) poor 
asthma control in daily life practice can actually lower the burden of the disease 
in the asthma population and make a difference for at least some of our patients 
with asthma.
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on the development and expression of 
asthma is complex and interactive. for 
instance a person can be genetically 
predisposed to develop airway hyper-
responsiveness but may not develop 
subsequent asthma, without specific 
exposure to allergens. 
Chapters 2 through 4 examine four 
possible risk factors: (asymptomatic) 
airway hyperresponsiveness (ahr), 
the presence of symptoms, allergy as 
measured by phadiatop test4 and gp 
diagnosed allergic rhinitis. 
Asymptomatic airway hy-
perresponsiveness (AhR)
it has been suggested that the pres-
ence of ahr without symptoms is an 
early, pre-clinical state in the patholog-
ical process of developing asthma5-8. if 
this were the case it would be advis-
able that patients exhibiting this condi-
tion should get treatment to prevent 
the development of asthma with the 
occurrence of irreversible structural 
and functional changes in the airways. 
in Chapters 2 and 3, a 14 year follow-
up study is reported using a cohort 
of adolescents of a general popula-
tion. this study demonstrated that 
asymptomatic ahr is not a risk factor 
for asthma. therefore, screening for 
asymptomatic ahr in a symptom-free 
population during adolescence cannot 
be advised to identify subjects at risk 
for developing asthma. this is espe-
cially the case because the histamine 
provocation test that measures ahr is 
time consuming and bothersome for 
the patient. 
however, as discussed before, the 
mechanisms whereby several factors 
influence the development and ex-
pression of asthma are complex and in-
teractive. other factors, such as atopy, 
besides or together with ahr, may 
influence the development of asthma. 
this might explain why in some stud-
ies it is found that asymptomatic ahr 
is a risk factor for asthma5-8 and in this 
thesis it is found not to be. further-
more, after the 14-years of follow-up 
it turned-out that ahr in combination 
with respiratory symptoms was not a 
consistent characteristic on the indi-
vidual patient level, during the period 
of adolescence to adulthood: less than 
half of those hyperresponsive at base-
line, remained so during the observa-
tion period. this supports the view of 
ahr as a dynamic process rather than 
a consistent characteristic and this 
hampers its use for screening. 
Respiratory symptoms
Chapters 2 and 3 study the relation 
between the presence of respiratory 
symptoms in adolescence and the 
subsequent development of asthma 
in adulthood. the presence of symp-
toms may imply that there are already 
airway changes like airway obstruc-
tion, induced by asthma. however, 
respiratory symptoms are not specific 
to asthma and Chapter 2 reports that 
there were adolescents that had re-
spiratory symptoms (chronic chough 
with or without phleghm, wheezing 
and tightness with wheezing) without 
the presence of other asthma-related 
features like ahr or airway obstruc-
tion. nevertheless, the presence of 
these respiratory symptoms signifi-
cantly increased the chance of having 
asthma diagnosed by the gp in later 
years. however, Chapter 2 was solely 
based on the gp diagnosis. in order 
to study the prospective relationship 
between respiratory symptoms and 
asthma better, Chapter 3 was based on 
the same cohort but the asthma diag-
nosis used in this study was based on a 
reassessment of the subjects using the 
General discussion 
oBjeCTIves And MAIn ConCLusIons 
The main objectives of the studies in this thesis were to contribute to timely diagnosis of asthma 
and detection of uncontrolled asthma in order to improve the outcome of treatment.  
The main findings of this thesis are the following:
1. airway hyperresponsiveness (ahr) 
in the absence of symptoms in adoles-
cence was not a risk factor of asthma in 
adulthood (Chapter 2 and 3).
2. ahr in combination with respira-
tory symptoms was not a consistent 
patient characteristic (Chapter 3).
3. the presence of allergy assessed 
by a phadiatop test in adolescence in-
creased the risk for the development 
of asthma in adulthood (Chapter 3).
4. a gp diagnosis of allergic rhinitis 
was a risk factor for a general practi-
tioner (gp) diagnosis of asthma (Chap-
ter 4).
5. the asthma Control Question-
naire (aCQ) can be used to distinguish 
asthma patients with good symptom 
control from those with poor symptom 
control (Chapter 5).
6. postal mailing of the aCQ can be an 
appropriate starting point to identify 
patients in a family practice who have 
suboptimal control of asthma symp-
toms (Chapter 6).
7. more than half of the respondents 
to the aCQ have suboptimal control of 
asthma symptoms (Chapter 6).
Before giving recommendations for 
further research, the main findings of 
the studies in this thesis will be dis-
cussed in the context of current litera-
ture. 
as explained in Chapter 1, the figure 
below reflects a simplified version of 
a common pathway of a patient with 
diagnosed asthma.  the studies in this 
thesis describe two parts of the so-
called ‘asthma pathway’ in Chapters 2 
through 4, and in Chapters 5 through 
7:
Risk factors
primary prevention of asthma would 
be the ultimate approach to avoid ir-
reversible and structural airway ab-
normalities caused by the disease. 
however, as primary prevention is not 
possible, a timely diagnosis of asthma 
followed by effective treatment is the 
best feasible approach to minimise the 
negative effects of the disease1. 
asthma is most frequently diag-
nosed in general practice and general 
practitioners (gp) use risk-patterns of 
patients when diagnosing chronic dis-
eases like asthma.2;3 therefore, better 
identification of patients at high risk 
for asthma can help timely recognition 
and diagnosis of asthma, which allows 
gps to start a course of preventative 
measures to avoid the development of 
symptomatic asthma. 
in order to start timely measures it 
is important to distinguish between 
factors that are precursors of asthma 
and factors that support the diagnosis 
of asthma or trigger the symptoms of 
asthma. precursor factors may include 
gender, obesity and genetic predis-
position to atopy or airway hyperre-
sponsiveness1. factors that can trigger 
asthma are environmental factors like 
indoor as well as outdoor allergens, 
infections, occupational sensitizers or 
tobacco smoke. however, their effect 
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same symptom questionnaire, spirom-
etry and histamine provocation test. 
furthermore the definition of being 
symptomatic (based on the answers of 
the symptom questionnaire) in Chap-
ter 3 was at time of the reassessment 
adjusted to the most recent gina 
guidelines. it included breathlessness 
whereas this feature was not included 
in the symptomatic definition used in 
Chapter 2. in contrast to the findings 
in Chapter 2, here the analysis did not 
confirm that the presence of symp-
toms increased the risk for asthma. al-
though the same subjects were being 
studied the ‘symptomatic definition’ 
used in Chapter 3 lead to a bigger but 
probably also a more accurate group of 
symptomatic subjects. these two dif-
ferences, change of symptomatic defi-
nition and asthma definition, possibly 
explain the discrepancy in the results. 
Allergy and 
allergic rhinitis 
the study in Chapter 3 found that ad-
olescents of the cohort with a positive 
allergy test, in the form of a phadiatop 
test4, had an increased risk of asthma 
in adulthood. this leads to the recom-
mendation that gps should be aware of 
the potentially increased risk of allergy 
for the development of asthma while 
growing to maturity. however, further 
research is needed to give better in-
sight in the natural history of asthma 
in relation to allergy. the cohort de-
scribed in Chapter 3 was selected on 
age (adolescents), so unfortunately the 
results cannot be generalized to other 
age groups. Still, the findings are in line 
with other studies that were done with 
different agegroups.9;10
the study described in Chapter 4 
was based on patients with a wide age 
range and a gp-mediated diagnosis 
of allergic rhinitis. the study assessed 
their risk for asthma in comparison to 
a control group that was matched for 
age, gender, social status, and general 
practice. the study found that a diag-
nosis of allergic rhinitis increased the 
risk of asthma later in life almost 5 
times. this is in line with the findings of 
Chapter 3. allergic rhinitis, like allergy, 
can be seen as an ‘allergic expression’ 
of atopy. other studies confirm that 
atopy is a risk factor for asthma11;12. 
next to the epidemiologic evidence of 
the relation between allergic rhinitis 
and asthma, there are also pathophysi-
ologic data linking asthma and rhinitis. 
the upper and lower airways may be 
influenced by a common inflammatory 
process, which can be sustained and 
amplified by similar mechanisms.13-15 
in conclusion, the presence of allergy 
or allergic rhinitis increases the risk 
for asthma. for gps, this implies that 
diagnosing allergic rhinitis or allergy 
should trigger diagnostic awareness 
of asthma. furthermore, proactive di-
agnosis and treatment of asthma may 
be warranted for patients with allergic 
rhinitis or allergy. 
AsThMA ConTRoL 
once asthma is diagnosed, it is im-
portant to obtain lasting control of 
signs and symptoms. this often re-
quires long-term, (non-) pharmaco-
logical treatment as there is no cure 
for asthma. to ‘achieve and maintain 
control of symptoms’ is one of the 
main goals for successful management 
of asthma (gina)1. there is evidence 
that better asthma control improves 
the overall health of asthma patients16. 
nevertheless, despite the high prior-
ity of achieving good asthma control 
and the availability of highly effective 
pharmacotherapy, poorly controlled 
asthma is reported in up to 55-95 
percent of patients.17;18 poor patient 
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compliance, knowledge of asthma 
medication, adherence towards regu-
lar control consultations, and the pres-
ence of allergic rhinitis can be explana-
tions for this suboptimal control. 19-21 
further, there are indications that pa-
tients as well as physicians overestimate 
the level of asthma control.17;18 there-
fore, as discussed in Chapter 7, a simple, 
valid method to identify suboptimal or 
poor asthma control would therefore 
be not only relevant for clinical stud-
ies but would also enable gps to focus 
their attention to those in greatest need 
of their attention in order to lower the 
burden of the disease in the population. 
determination of direct markers of air-
way inflammation by means of induced 
sputum eosinophilia and endobron-
chial biopsy probably ascertain asthma 
control most accurately, even before 
airway inflammation causes airway 
damage with subsequent symptoms22. 
however the performance of endo-
bronchial biopsy and induced sputum 
eosinophilia is unsuitable for routine 
clinical application in general practice.23 
Similarly, the technique of exhaled nitric 
oxide measuring24 is also unsuitable for 
routine application at present. thus, at 
this moment, probably the best feasible 
way to optimize asthma treatment in 
the daily practice of primary care is the 
measurement of asthma control by 
means of asthma symptoms.
Besides the presence of lung function 
abnormalities, an increase of bronchial 
symptoms has been reported to be an 
essential part of true loss of asthma 
control1;25. Several questionnaires have 
been developed to measure asthma 
symptoms26;27; however, these symp-
tom questionnaires were, until now, 
not validated to identify patients with 
uncontrolled asthma in primary care. 
the studies in Chapters 5 and 6 inves-
tigated whether it is possible to differ-
entiate between patients with well and 
poorly controlled asthma with the use 
of a short questionnaire (the asthma 
Control Questionnaire, aCQ) mailed by 
post. it also further explored the status 
of asthma control of asthma patients 
in general practice that returned a 
mailed aCQ. 
Measuring asthma control
Chapter 5 explored whether valid 
differentiation was possible in general 
practice between asthma patients with 
controlled and uncontrolled asthma 
symptoms, on the basis of a short 
symptom questionnaire: the asthma 
Control Questionnaire (aCQ). the re-
sults of this study showed that the sum 
score of the aCQ allows for differen-
tiation between patients with good, 
suboptimal, and poor asthma control. 
however, the cut-off value for the 
aCQ sum score that determines such 
differentiation must be set according 
to an appropriate level of goals given 
resources. when resources are lim-
ited, the goal might be only to detect 
patients with poorly controlled asthma 
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aCQ would be an interesting field for 
further research.
ReCoMMendATIons 
FoR FuTuRe  
ReseARCh
only a minority of patients with al-
lergy and allergic rhinitis develops 
asthma and in order to support the 
diagnostic process in general practice 
more focus should be placed on iden-
tifying allergic subjects at high risk to 
develop asthma. therefore, further re-
search is needed to give better insight 
in the course of asthma in relation to al-
lergy and allergic rhinitis. for instance, 
it would be interesting to evaluate how 
often patients with allergic rhinitis also 
suffer from undisclosed asthma (symp-
toms) at the time of diagnosis. what is 
the role of allergy? do non-allergic rhi-
nitis patients (e.g. rhinitis patients with 
a negative phadiatop test or skin prick 
test) also have a higher risk for asthma 
than non-allergic patients without rhi-
nitis symptoms? are there other fac-
tors that influence the risk for asthma, 
like certain genes? as most allergic rhi-
nitis and asthma patients are treated in 
general practice this would be the ideal 
setting for these studies.
furthermore it would be interesting 
to investigate whether treatment or 
preventive measures of specific high-
risk groups can prevent the develop-
ment of symptomatic asthma. for 
instance, does treatment of allergic 
rhinitis patients with nasal corticoste-
roids lower the risk of asthma com-
pared to allergic rhinitis patients that 
only use antihistamines
another important finding of the 
studies in this thesis was that the aCQ 
is able to differentiate between pa-
tients with good, suboptimal, and poor 
asthma control. furthermore, as the 
majority of adult asthma patients re-
sponded to a postal mailing of the aCQ, 
this instrument can be used to identify 
patients with suboptimal control of 
their disease. Still, further research is 
needed to establish whether identify-
ing poorly controlled asthma patients 
with the aCQ followed by interventions 
will actually improve asthma control. in 
this respect it is also important to find 
out whether the aCQ should be admin-
istered by post, internet, telephone, by 
the doctor to the patient, or whether 
the aCQ should be incorporated into 
the clinician-patient conversation dur-
ing the asthma treatment program in 
order to improve asthma control. 
another important field for further 
research would be to explore why sub-
optimally controlled asthma patients 
choose not to seek help even though 
they experience symptoms. involve-
ment and motivation of patients in 
their asthma treatment is an important 
area for further research. 
at the present time optimal asthma 
control is the ultimate goal. an inter-
esting field of research would be to 
investigate whether optimal control 
can be reached in all asthma patients 
and whether patients regard this goal 
as the most preferable option.
finally, further research is needed in 
general practice to find the best way to 
assess asthma control or asthma status 
in order to support optimal treatment 
for asthma patients.
symptoms and an aCQ cutoff value 
of >6 points would seem appropriate. 
when there are fewer time or labor 
restraints an aCQ cutoff value of >3 
points seems appropriate to also iden-
tify patients with suboptimal asthma 
control. further research is needed to 
establish guidelines on which cut-off 
value of the aCQ may be best to opti-
mize asthma control.
Reaching patients with 
poor asthma control
for an instrument to differentiate 
between well controlled asthma and 
poorly controlled asthma, it is essen-
tial to actually reach potential poorly 
controlled asthma patients. as not all 
asthma patients consult their gp on a 
regular basis, other means than usual 
care should be used to reach them. 
the study described in Chapter 6 
found that more than three quarters 
of adult asthma patients of six general 
practices responded to a postal mailing 
with the aCQ. among these responders 
there were patients who had recently 
consulted their gp (visitors) and patients 
who had not visited their gp recently 
(non visitors). as can be expected, poor 
asthma control was found among non 
visitors. this means that these patients 
did not visit their gp even though their 
asthma was symptomatic and impacted 
their daily functioning. these findings 
could indicate that those patients ac-
cept their level of asthma control as it 
is, and choose not to change current 
or start new treatment. this would 
be in line with other studies’ findings 
that part of the non-attending asthma 
patients believe that their asthma is 
so mild that possible advantages of an 
asthma review do not outweigh the 
inconvenience of attending the prac-
tice.28;29  however, it could also be the 
case these patients are misgauging the 
level of their asthma control because 
they may be unaware of the possibility 
of improvement. for gps, this could im-
ply that simply bringing the poor status 
of control to the attention of the asthma 
patients would help to improve poor 
asthma control.  while the treatment of 
asthma is both the patient’s and health-
care worker’s responsibility, by inform-
ing patients properly about the disease 
and its possible goals for treatment, gps 
or other healthcare professionals can 
help guide patients to decide whether 
or not the advisable goals correspond 
with their personal goals.
another relevant finding of Chapter 6 
for daily practice was that recent consul-
tations for asthma-related complaints 
did not automatically lead to good 
asthma control. the largest number of 
patients with a suboptimal control of 
their asthma had recently consulted 
their gp for asthma-related complaints. 
this may be interpreted as that asthma 
treatment is still approached from the 
concept of asthma as an episodic dis-
order, therefore focusing on asthma-re-
lated problems present here and now, 
and disregarding the longer term im-
pact of the disease on patients’ health 
status.30;31 furthermore it supports the 
view that gps are often not aware of the 
poor asthma control of their patients. 
the specific assessment of asthma 
control is not a part of the routine in 
current daily care practice. it is recom-
mended that the aCQ is possibly incor-
porated into patient-clinician commu-
nications in order to improve asthma 
control. it is not recommended, how-
ever, that the aCQ replaces a face-to-
face review of the patient’s unique 
asthma situation and other medical 
and socio economic difficulties that 
may complicate asthma management. 
additional ways of implementing the 
Figure 1
Figuur 2, hoofdstuk 1 (zelfde als in hoofdstuk 8)
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ciation between asymptomatic ahr and 
allergy in adolescence, and the develop-
ment of asthma in adulthood in this co-
hort.  a reassessment of the respiratory 
status of a part of the above described 
cohort of adolescents was performed 14 
years after baseline (n=199). furthermore, 
of all the subjects (n=551) existing Cmr 
data were analyzed. asymptomatic ahr 
was not significantly related to asthma 14 
years later. therefore, screening for as-
ymptomatic airway hyperresponsiveness 
in adolescence cannot be recommended 
to identify subjects at risk of developing 
asthma. on the contrary, the presence of 
allergy in adolescence increased the risk 
for an asthma diagnosis in adulthood four 
times. furthermore (asymptomatic) 
ahr was no constant factor from ado-
lescence to adulthood in primary care 
after 14 yrs follow-up. 
Chapter 4
this chapter assessed prospectively 
whether physician diagnosed allergic 
rhinitis is a risk factor for the diagnosis 
of asthma in a large primary care pop-
ulation. this study also used the Cmr 
population. an historic cohort study 
was performed of life-time morbidity 
that had been recorded prospectively 
since 1967. Survival analysis was used 
to compare the risk of physician diag-
nosed asthma of allergic rhinitis pa-
tients (n = 2081) with matched controls 
(n = 4410) of the Cmr cohort. mean 
observation time was 8.4 years. 
it was found that a diagnosis of al-
lergic rhinitis was an independent risk 
factor for a diagnosis of asthma in our 
primary care study population, having 
physician diagnosed allergic rhinitis in-
creased the risk almost five fold for a 
future asthma diagnosis.
Chapter 5  
the study in this chapter explored 
whether valid differentiation is pos-
sible between asthma patients with 
controlled and uncontrolled asthma 
symptoms, with the asthma Control 
Questionnaire (aCQ).
in a multi centre, cross-sectional 
study, patients were classified into lev-
els of asthma symptom control based 
on a diary card registration. of 108 
asthma patients complete data were 
obtained and the association between 
the diary asthma symptom control 
category and aCQ sum score was as-
sessed. 
our results showed that discrimina-
tion between asthma patients with 
controlled and uncontrolled asthma 
symptoms, based upon the aCQ, is 
possible. thus, the aCQ may be an im-
portant tool for healthcare profession-
als who aim to optimize the level of 
asthma control in their patient popula-
tion. generally it is found that a higher 
aCQ sum score is related to poorer 
asthma control. however, which ex-
act cutoff value is most appropriate 
depends on the goals a healthcare 
professional has. when resources are 
limited, the goal might be only to de-
tect patients with poorly controlled 
asthma symptoms and an aCQ cutoff 
value of >6 points would seem appro-
priate. when there are less restraints 
in time or manpower an aCQ cutoff 
value of >3 points seems appropriate 
to identify also patients with a subopti-
mal asthma control. 
Chapter 6
in this chapter it was studied whether 
a postal mailing of the aCQ can be used 
to reach (potential) poorly controlled 
asthma patients in general practice. 
in this study, we sent 434 asthma pa-
tients from 6  general practices an 
aCQ by mail. patients with an aCQ 
sum score (total score) more than 3 
Chapter 1
in this chapter a general intro-
duction on this thesis is given. 
asthma is a common chronic inflamma-
tory respiratory disease which causes 
airway obstruction. in the netherlands 
the majority of asthma patients is di-
agnosed and treated in primary care. 
when symptomatic asthma has devel-
oped, often irreversible structural and 
functional changes in the airways have 
occurred. therefore it is important to 
detect persons at risk of asthma as early 
as possible to start treatment. in order 
to detect persons at risk, risk factors for 
asthma have to be identified. Several 
factors like asymptomatic airway hyper-
responsiveness (ahr), allergy and aller-
gic rhinitis are associated with asthma. 
unknown is whether these factors are 
actual risk factors that precede asthma, 
are conditions that are consistent with (a 
very mild state of) asthma, or are con-
current conditions. in chapters 2, 3 and 4 
of this thesis, these factors are studied.
there is no cure for asthma, but appro-
priate management most often results 
in the achievement of control of the 
disease meaning a minimum of chronic 
symptoms, no exacerbations, minimal 
need for as-required β2-agonists, no 
limitations to daily activities and a nor-
mal lung function. Still, poorly controlled 
asthma is reported in a substantial part 
of patients. there are indications that 
patients and physicians overestimate 
the level of asthma control. this means 
that a tool that can identify asthma pa-
tients with poorly controlled asthma can 
be helpful. in chapters 5 and 6 it is stud-
ied whether the asthma Control Ques-
tionnaire (aCQ) can differentiate be-
tween asthma patients with adequately 
controlled and poorly controlled asthma 
symptoms. an opinion about the rel-
evance of asthma control measuring 
for daily life practice is formulated in 
chapter 7.
Chapter 2
in this chapter the natural history 
of respiratory tract complaints and 
asthma is studied. a cohort (n=551) 
consisting of children and young adults 
that was studied in 1989 (baseline), 
was followed up until 2000. this cohort 
consisted of patients that were regis-
tered within one of the four affiliated 
Continuous morbidity registration 
(Cmr) general practices of the nijme-
gen department of general practice. 
the Cmr is a general practice research 
network and provides a database in 
which the physician diagnoses (mor-
bidity) for each patient and for each 
episode of outpatient care are coded 
and recorded. it was found that neither 
airway hyperresponsiveness (ahr) nor 
the presence of asthma symptoms at 
baseline did result in a difference in 
the number of gp visits for upper re-
spiratory infections or lower respira-
tory infections over the next 10 years. 
the presence of asthma symptoms did 
correlate with an increased risk of an 
asthma diagnosis or allergic rhinitis. 
Chapter 3
in this chapter the aim was to assess 
prospectively whether there is an asso-
Summary
In this thesis studies on possible risk factors for asthma and indicators of poor 
asthma control are described. The general objectives are to contribute to timely 
diagnosis of asthma and detection of patients with poorly controlled asthma.
Samenvatting / Summary
6  Asthma in general practice         
Asthma in general practice  
astma controle door astmapatiënten 
en hun artsen. dit betekent dat een 
instrument dat astmapatiënten kan 
identificeren met slecht gecontroleerd 
astma erg nuttig kan zijn. in de hoofd-
stukken 5 en 6 is onderzocht of de 
asthma Control Questionnaire (aCQ) 
zodanig gebruikt kan worden en dus 
onderscheid kan maken tussen astma 
patiënten met goede astma symptoom 
controle en slechte astma symptoom 
controle.
hoofdstuk 2
in dit hoofdstuk wordt het natuur-
lijke beloop van de luchtwegklachten 
en astma klachten onderzocht. een 
geboortecohort (n = 551), bestaande 
uit kinderen en jong volwassenen 
dat voor het eerst werd onderzocht 
in 1989 (baseline), wordt gevolgd tot 
2000. dit geboortecohort bestaat uit 
patiënten van de Continue morbidit-
eit registratie (Cmr) van de vakgroep 
huisartsgeneeskunde nijmegen. de 
Cmr is een onderzoeksnetwerk van 
vier huisartspraktijken waarbij bij elke 
patiënt waar een diagnose gesteld 
wordt door een dokter, huisarts of 
specialist (de ‘morbiditeit’), wordt ge-
codeerd en geregistreerd in een data-
base. uit deze studie bleek dat de helft 
van de bekende astmapatiënten bij 
het begin van de studie geen verdere 
bezoeken aan de huisarts had in ver-
loop van 10 jaar. Bovendien bleek dat 
noch bronchiale hyperreactiviteit noch 
de aanwezigheid van astmasymp-
tomen bij baseline resulteerde in een 
verschil in het aantal bezoeken voor 
bovenste luchtweginfecties of lagere 
luchtweginfecties in het verloop van 
de 10 jaar. de aanwezigheid van ast-
masymptomen correleerde wel met 
een verhoogd risico op een diagnose 
astma.
hoofdstuk 3
dit hoofdstuk had ten doel om 
prospectief te bekijken of er een as-
sociatie is tussen asymptomatische 
bronchiale hyperreactiviteit en allergie 
tijdens de pubertijd en de ontwikkel-
ing van astma op volwassen leeftijd in 
het bovenbeschreven cohort. een her-
beoordeling van de luchtwegstatus van 
een deel van het hierboven beschreven 
cohort van adolescenten(n = 199) 
werd uitgevoerd 14 jaar na de baseline 
meting. en bij alle deelnemers (n=551) 
werd gekeken naar de beschikbare in-
formatie in de Cmr database. het heb-
ben van asymptomatische bronchiale 
hyperreactiviteit bleek het risico op 
een diagnose astma 14 jaar later niet 
te verhogen of te verlagen. daarnaast 
bleek (asymptomatische) bronchiale 
hyperreactiviteit geen constante fac-
tor te zijn. in deze studie wordt dus 
geconcludeerd dat om astma op te 
sporen bij volwassenen het niet zinvol 
lijkt om te screenen op asymptoma-
tische bronchiale hyperreactiviteit in 
de pubertijd. aan de andere kant bleek 
wel dat de aanwezigheid van allergie in 
de pubertijd het risico op een diagnose 
astma op volwassen leeftijd vier maal 
verhoogde. dokters zouden dus na het 
stellen van een diagnose ‘allergie’ bij 
pubers alert moeten zijn op mogeli-
jke ontwikkeling van astma op latere 
leeftijd. 
hoofdstuk 4
dit hoofdstuk betreft een prospec-
tieve studie naar allergische rhini-
tis als risicofactor voor astma. deze 
studie maakt wederom gebruik van 
de Cmr database en de onderzochte 
personen maken dus deel uit van 
een eerstelijns populatie. een cohort 
allergische rhinitis patiënten werd 
vergeleken met een gematchte con-
trole groep. onderzocht werd of de 
were considered to have suboptimally 
controlled asthma symptoms. more 
than three quarters of the patients 
responded and more than half of 
these responders had not visited the 
gp recently. furthermore, half of the 
asthma patients that responded had 
suboptimally controlled asthma symp-
toms. in conclusion, postal mailing of 
the aCQ can be an appropriate starting 
point to identify patients in a general 
practice who have suboptimal control 
of asthma symptoms.
Chapter 7
Based on the results in chapter 5 and 
6, in this chapter the opinion is formu-
lated that asthma control is not just 
relevant for clinical studies but can also 
be relevant for daily life practice. 
Chapter 8
in this chapter the results of the dif-
ferent studies are discussed.this thesis 
shows that being allergic (assessed by 
phadiatoptest) and having a doctors 
diagnosis of allergic rhinitis are risk 
factors for asthma and not just con-
current conditions. on the contrary, it 
was found that having asymptomatic 
airway hyperresponsiveness in adoles-
cence is not a risk factor for asthma in 
adulthood. 
furthermore it was found that (postal 
mailing of) the aCQ can be used to de-
tect asthma patients with suboptimal 
to poor asthma control.
Besides these findings the implica-
tions are discussed and some recom-
mendations for further research are 
given.
hoofdstuk 1
astma is een veel voorkomende 
chronische inflammatoire luchtwe-
gaandoening waarbij de luchtwegen 
wisselend vernauwd zijn. in neder-
land wordt de meerderheid van de 
astmapatiënten gediagnosticeerd en 
behandeld in de eerstelijns gezond-
heidszorg. wanneer symptomatisch 
astma zich heeft ontwikkeld hebben er 
helaas vaak onomkeerbare structurele 
en functionele veranderingen in de 
luchtwegen plaatsgevonden. daarom 
is het belangrijk om personen met een 
hoog risico op astma zo vroeg mogelijk 
op te sporen zodat vroeg gestart kan 
worden met een behandeling. om 
deze mensen met een hoog risico op 
astma op te kunnen sporen moeten 
er eerst risicofactoren voor astma 
geïdentificeerd worden. verschillende 
factoren zoals asymptomatische bron-
chiale hyperreactiviteit, allergie en al-
lergische rhinitis (in de volksmond ook 
wel ‘hooikoorts’ genoemd) zijn geasso-
cieerd met astma. onbekend is nog of 
deze factoren werkelijke risicofactoren 
zijn die voorafgaan aan de eigenlijke 
ziekte, of tekenen zijn die wijzen op 
een (zeer milde vorm van) astma, of 
toevallige, tegelijkertijd, optredende 
factoren. in de hoofdstukken 2, 3 en 4 
van dit proefschrift worden deze facto-
ren nader bestudeerd.
er is helaas nu nog geen remedie 
voor astma, maar een goede, pas-
sende behandeling resulteert meestal 
in het bereiken van een goede controle 
van de ziekte. desondanks wordt er in 
een substantieel deel van de patiënten 
nog steeds slecht gecontroleerd astma 
gevonden. dit heeft meerdere oorza-
ken waaronder waarschijnlijk ook 
de overschatting van het niveau van 
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hebben van asymptomatische bron-
chiale hyperreactiviteit in de pubertijd 
geen risicofactor is voor astma. verder 
is gevonden dat de aCQ goed gebruikt 
kan worden om astmapatiënten met 
een slechte astma controle op te spo-
ren. naast deze bevindingen worden 
de mogelijke implicaties hiervan be-
sproken en worden aanbevelingen 
voor toekomstig onderzoek gedaan.
Samenvatting / Summary
mensen met allergische rhinitis meer 
kans hadden op het krijgen van een 
astma-diagnose in de toekomst dan 
mensen zonder allergische rhinitis. de 
studie populatie bestond uit 6491 per-
sonen (waarvan 2081 patiënten met 
allergische rhinitis), met een gemid-
delde follow-up duur van ruim 8 jaar. 
het bleek dat een diagnose van ar een 
onafhankelijke risicofactor is voor een 
diagnose astma in onze studie groep. 
het bleek dat het hebben van een diag-
nose allergische rhinitis het risico bijna 
vijf maal verhoogd op het krijgen van 
een astma diagnose in de toekomst.
hoofdstuk 5 
in dit hoofdstuk wordt onderzocht 
of met behulp van een korte vragen-
lijst, de asthma Control Question-
naire (aCQ), onderscheid gemaakt 
kan worden tussen astma patiënten 
met goed gecontroleerde en slecht 
gecontroleerde astma symptomen. in 
een multi-centrum, cross-sectionele 
studie, werden patiënten (n=108) in-
gedeeld in 4 niveaus van astma symp-
toom controle met behulp van een 
dagboek-registratie. onze resultaten 
laten zien dat het mogelijk is om met 
behulp van de aCQ onderscheid te 
maken tussen astma patiënten met 
goed gecontroleerde en slecht gecon-
troleerde astma symptomen. over het 
algemeen geldt dat hoe hoger de som-
score is, hoe slechter de astma con-
trole is. echter, welke afkapwaarde van 
de aCQ somscore het meest geschikt 
is, hangt van de doelstellingen van de 
zorgverlener af. wanneer de middelen 
beperkt zijn, zou het doel kunnen zijn 
om alleen patiënten op te sporen met 
zeer slechte astma symptoom controle, 
en dan lijkt een aCQ afkapwaarde van 
6 punten het meest aangewezen te 
zijn. maar om ook mensen met sub-
optimale astma controle te identifice-
ren zou een afkapwaarde van 3 aan te 
raden zijn.  
hoofdstuk 6
dit hoofdstuk betreft een studie waar- 
in gekeken wordt of het per post op- 
sturen van de aCQ gebruikt kan worden 
om (potentiëel) slecht gecontroleerde 
astmapatiënten in de huisartspraktijk 
op te sporen. in deze observationele 
studie stuurden wij 434 astmapatiënten 
van 6 nederlandse huisartspraktijken 
een aCQ per post. patiënten met een 
aCQ somscore van meer dan 3 werden 
aangemerkt als het hebben van sub-
optimaal gecontroleerde astma symp-
tomen. meer dan driekwart van de 
patiënten stuurde de aCQ terug. van 
de mensen die reageerden had meer 
dan de helft de afgelopen 2 jaar niet de 
huisarts bezocht. verder bleek meer 
dan de helft van de astma patiënten 
die gereageerd hadden suboptimaal 
gecontroleerde astma symptomen 
te hebben. het lijkt dus mogelijk om 
slecht gecontroleerde astma patiënten 
te bereiken en op te sporen met behulp 
van de per post verstuurde aCQ.
hoofdstuk 7
gebaseerd op de resultaten in hoofd-
stuk 5 en 6 wordt in dit hoofdstuk het 
advies geformuleerd dat het meten 
van astma controle niet alleen relevant 
is voor klinische studies, maar dat het 
ook relevant kan zijn voor de dagelijkse 
praktijk.
hoofdstuk 8
dit hoofdstuk beschouwt het proef-
schrift en plaatst de bovengenoemde 
bevindingen in het licht van de hui-
dige wetenschappelijke kennis. dit 
proefschrift laat zien dat het hebben 
van allergie en allergische rhinitis risi-
cofactoren zijn voor het ontwikkelen 
van astma. daarentegen blijkt dat het 
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opleiding bijgestaan hebben. in het 
bijzonder waren dat els Slagmeulen, 
marieke gijsbers en moniek arents. 
ook wil ik ‘dames van de voha’ be-
danken: michelle teunissen, vanessa 
Blom,franka derks, karlijn engelen, 
Caroline visser en esther diepenbroek. 
een goede planning maken voor een 
‘normaal’ aios traject is al passen en 
meten, voeg daar een promotietra-
ject en zwangerschap aan toe en dan 
wordt het helemaal een gepuzzel. Be-
dankt voor het geduldig antwoorden en 
meedenken over de vele vragen die er 
ontstonden. in dit licht wil ik ook petra 
Stins van de SBoh bedanken. 
 fleur van rijn wil ik bedanken voor 
de vormgeving van dit proefschrift, 
door jou is het dan toch een echt 
boekje geworden. ondanks de tijds-
nood en het switchen naar ‘plan B’ ziet 
het er niet uit alsof er ‘alleen maar’ een 
nietje doorheen zit en ben ik trots op 
het resultaat. Bedankt!
monica na, thank you for your com-
ments on my english.
roel, Letteke, arjen , Liesbeth, ma-
thieu, esther, nadia, Judith, Janneke, 
mariska, margo, dion, ilse, ‘de tan-
tetjes’: elly, Christel en inge,  maar ook 
al mijn andere vrienden en leden van 
mijn  familie wil ik graag noemen in dit 
dankwoord. ook al zullen de meesten 
niet weten wat die asymptomatische 
bronchiale hyperreactiviteit nou in-
houdt, toch hebben jullie telkens weer 
oprechte interesse getoond voor mijn 
proefschrift.  door die interesse en de 
relativerende opmerkingen hebben 
jullie mij aangespoord om toch mijn 
proefschrift af temaken. Bedankt!!
elly en ton,  bedankt voor jullie inte-
resse en het vele oppassen op teun. 
Caroline van wayenburg, bijna tegelij-
kertijd hebben we samen het hele aio-
tho-traject afgelegd. ook al hebben 
we inhoudelijk weinig samengewerkt, 
ik kan wel stellen dat ik dankzij onze 
‘sociale samenwerking’ dit proefschrift 
toch helemaal afgerond heb. Super dat 
je ook nog mijn paranimf bent! 
noor Lammerts. Zonder jouw 
enthousiasme tijdens het aanbod om 
een promotie traject in gaan zou ik het 
waarschijnlijk niet gedaan hebben. fijn 
dat je er altijd voor me bent. ook al is 
de afstand maastricht-nijmegen wel 
erg ver, gelukkig is de afstand niet te 
groot gebleken. fijn dat jij mijn para-
nimf bent!
Lieve mama en papa, het is onbe-
schrijfelijk hoeveel ik aan jullie te dan-
ken heb. fijn dat jullie altijd achter me 
hebben gestaan. Zonder jullie steun zou 
ik nooit zover gekomen zijn. Bedankt!
Lieve gerben, je zegt dat ik je niet 
hoef te noemen in dit dankwoord 
maar zonder jouw continue steun op 
alle vlakken zou ik echt al lang gestopt 
zijn….. geweldig dat wij samen ons 
leven delen. Jij en teun zorgen ervoor 
dat het thuis het allerleukste is.
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Astma is een veel voorkomende chronische 
luchtwegaandoening. Wanneer er sprake is 
van symptomatisch astma hebben er vaak 
onomkeerbare veranderingen in de luchtwe-
gen plaatsgevonden. daarom is het belangrijk 
om personen met een hoog risico op astma 
zo vroeg mogelijk op te sporen. uit de onder-
zoeken beschreven in dit proefschrift komt naar 
voren dat bepaalde groepen met een allergie 
of allergische rhinitis (‘hooikoorts’) meer kans 
hebben op het krijgen van astma. Het hebben 
van asymptomatische bronchiale hyperreactiv-
iteit in de puberteit vergroot die kans niet.
Een goede behandeling resulteert meestal in 
het bereiken van een goede astma controle. In 
een groot deel van de patiënten is dit helaas 
niet het geval. Waarschijnlijk komt dit deels om-
dat astmapatiënten en hun artsen de mate van 
astma controle overschatten. In dit proefschrift 
wordt beschreven dat de Asthma Control Ques-
tionnaire (ACQ) op een gemakkelijke manier 
onderscheid kan maken tussen astma patiënten 
met goede en slechte astma controle.
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